Follow us on:

REFERENCES ON API-ONCOLOGY

There are thousands of references on articles, abstracts, lectures, conferences, etc. on the preventative and therapeutical use of bee hive products against cancer. Here below you find some of them. For more such references study the “References” part at the end of each article on Api-Oncology.

References on the use of Propolis against cancer:

·        *** (1999)  –  Abstract of Papers – Pacific Northwest Apitherapy Conference, Vancouver, Canada, June,  12-14, 1998.
     Apitherapy Education Service – Apitronic Services, pp. 25 (***).

 

 

·        Arvouet – Grand, A. (1993)  –  Propolis extract. II. Wound healing the rat and rabbit,
     in J Pharm Belg., May-June, 48(3),  pp.171-78.

 

 

·        Bašic,I.,  Curic,S.,  Tadic,Z.,  Oršolic,N.,  Sulimanovic,D. (1995) (Croatia)  –  Antimetastatic activity of bee venom and water soluble derivatives of propolis in mice,
     in the XXXIV-Th. Apimondia Congress, Lausanne, Switzerland,  pp.135-136 (***-abstract).

 

 

·        Bašic,I.,  Oršolic,N.,  Brbot-Saranovich,A.,  Tadic,Zoran,  Sulimanovic,D. (1997) (Croatia)    Antimetastatic activity of propolis, caffeic acid phenethyl ester and caffeic acid against mammary carcinoma of CBA mouse,
    
in the XXXV-Th. Apimondia Congress, Antwerp, Belgium (***). [i]

 

 

·        Binder, Walter (1979) (Germany)  –  Kittharz-die antibiotische Alternative,
     in Naturheilpraxis, 5/1979 (***).
[ii]

 

 

·        Brodzicki, S.;  Srebro, Z. (1987) (Poland)  –  Mytotic Activity in the skin lesions treated with propolis evaluated  by autoradiography with 3-H-thymidine (French – abstract),
     in the XXXI-St. International  Congress of Apiculture,  Warsaw,  Poland, p.513 (***).

 

 

·        Cizmárik, J.;  Lahitova, N. (1997) (Slovakia)  –  Antimutagenity of propolis,
     in the XXXV-Th. Apimondia Congress, Antwerp, Belgium.

 

 

·        Derevici Adelina;  Popescu, Al. (1965) (Romania)    The action of propolis in vitro on  the  cells of the  Ehrlich Ascitic Tumour,
     in  the XX -Th. International Congress on Apiculture,  Bucharest, pp.539-43 (***).

 

 

·        Derevici Adelina,  Popescu,A. (1966) (Romania)  –  Azione in vitro del propolis sulle cellule del tumore ascitico di Ehrlich (Italian),
     in Riv. Vet.,  15,  pp.175-82.

 

 

·        Derevici Adelina;  Soru Eugenia;  Dima, V. (1967) (Romania)  –  The activity  of  an  extract  of propolis on an Ehrlich  Ascites  Carcinoma (abstract),
     in the XXI St. Apimondia Congress ,  Maryland, USA,  p.493 (***).

 

 

·        Derevici Adelina, Soru,E.,  Dima,V. (1972) (Romania)  –  The activity of an extract of propolis on an Ehrlich ascitic carcinoma (experiences in vitro),
     in the Second International Symposium on Propolis, Bratislava, Czechoslovakia.

 

 

·        Derevici Adelina (1974) (Romania)  –  Untersuchungen in Hinblick auf die krebshemmende Wirkung der Propolis bei Hamstern. Feststellungen und morphologische Angaben,
     in the First International Symposium on Apitherapy, Madrid, Spain,  pp.119-23.

 

 

·        El-Ghazaly MA, et al. (1995)  –  The use of aqueous propolis extract against radiation-induced damage,
     in Drugs Exp Clin Res.; 21(6),  pp.229-236 (***). [iii]

 

 

·        Grochowski,M.,  Bilinska,D.,  Stankiewicz (1985) (Poland)  –  The therapeutic effect of 3% propolis ointment  on race DBA/2H mice who suffers from skin burns infected afterwards with Pseudomonas aeruginosa (Romanian),
     in the XXX-Th. Apimondia Congress, Nagoya, Japan,  pp.426-28 (***).

 

 

·        Grunberger,D.,  Banerjee,R.,  Eisinger,K.,  Oltz,E.M.,  Efros,L.,  Caldwell,M.,  Esteevez,V.,  Nakanishi,K. (1988, 1991)  –  Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis,
     in Experientia (Monthly Journal of Pure and Applied Science), Mar. 15; 44(3),  pp.230-32 (***-abstract);
     in Kaal, 1991,  pp.22-24 (***).

 

 

·        Guarini,L., Su,Z.Z.,  Zucker,S.,  Lin,J.,  Grunberger,D.,  Fisher,P.B. (1992)  –  Growth inhibition and modulation of antigenic phenotype in human melanoma and glioblastoma multiforme cells by caffeic acid phenethyl ester (CAPE),
     in Cellular and Molecular Biology, 38(5),  pp.513-27.

 

 

·        HASHIMOTO, Takaharu; AGA, Hajime; TABUCHI, Akihiko; SHIBUYA, Takashi; CHAEN, Hiroto; FUKUDA, Shigeharu; KURIMOTO, Masashi (1998) (Japan)  –  Anti-Helicobacter pylori compounds in Brazilian propolis,
     in Natural Medicins 2,  pp.518-520. [iv]

 

 

·        Hermann, G. R.;  Bracamonte, J. A. (1990)  –  Propolis extract as a sunscreen agent,
     in Drug and Cosmetic Industry, 147(4),  p.38.

 

 

·        Hladon, B. et al. (1980) (Poland)  –  In vitro studies on the cytostatic activity of propolis extracts,
     in Arzneimittelforschung, 30, (11),  pp.1847-48.

 

 

·        Hladon,B.,  Ellnain-Wojtaszek,M.,  Nowak,G.,  Sikorska H.,  Kowalewski,Z. (1987) (Poland)    L’activité citostatique in vitro  de la propolis: autres études sur des fractions de l`extrait etherique Deep et leurs sous-fractions sesquiterpenoides (abstract),
     in the XXXI-St.
Apimondia Congress,  Warsaw, Poland,  pp.524-25 (***).

 

 

·        Hmelevskaia V.N.,  Vladimirova V.S.,  Baran,L.A.,  Chekman, V.V. (1965)  – Experiments with regard to using propolis to combat  irradiation reactions and diseases,
     in the XX-Th. International Congress on Apiculture,  Bucharest, Romania,  pp.503-05 (***).

 

 

·     Huleihel, M.;  Isahano,V.  (2001)  –  Effect of propolis extract on malignant cell transformation by moloney murine sarcoma virus,
      in Archives of Virology, March,  pp.1517-1526.

 

 

·        Inayama,S.,  Harimaya,K.,  Hori,H.,  Ohkura,T.,  Kawamata,T.,  Hikichi,M.,  Yokokura,T. (1984) (Japan)  –  Studies on non-sesquiterpenoid constituents of Gaillardia pulchella. II. Less lipophilic substances, methyl caffeate as an antitumor catecholic,
     in Chem. Pharm. Bull., 32,  pp.1135-41.

 

 

·        Iovan,D.,  Iliescu,E.,  Apetroaiei,N. (1975, 1981, 1990) (Romania)  –  Considerations on the treatment of some chronic ulcerous metritis  of cervix uteri with propolis products (Romanian),
     in Apicultura, 12/1975,  p.15 (***);
     in “Propolisul”, Apimondia Publishing House, Bucharest, 1975,  pp.154-57;
     in “Propolis”, Editura Apimondia, Bucuresti, Romania, editia a treia, 1981,  pp.176-78 (Romanian) (***) si in editia a IV-a, 1990,  pp.245-47 (Romanian) (***).

 

 

·        Jaiswal, A. K.; Venugopal, R.; Mucha, J.; Carothers, A. M.;  Grunberger, D. (1997)  –  Caffeic acid phenethyl ester stimulates human antioxidant response element-mediated expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene,
     in Cancer Res, 57(3),  pp.440-46 (***-abstract) [v].

 

 

·        Kern,M.,  Soba Erika,  Budihna,M. (1978) (Yugoslavia)  –  Apikompleks, a prophylactic product against radiomucositis,
     in the Third International Symposium on Apitherapy, Portoroz, Yugoslavia,  pp.338-40(French),  pp.340-41(English abstract),  p.341 (German, Russian and Spanish abstract) (***).

 

 

·        Lambert, Priscila (1999) (Brazil)  – Pesquisa mostra que resina produzida pelas abelhas impede o crescimento de células cancerígenas. Própolis pode proteger corpo de tumores,
     in Folha de São Paulo, 12 de Julho de 1999 (***).
[vi]

 

 

·        Lambert, Priscila (1999) (Brazil)  – Própolis puede proteger del sol,
     in Folha de São Paulo, 12 de Julho de 1999 (***).
[vii]

 

 

·        Leipus, I. (1975) (U.S.S.R.)  –  Treatment of malignant tumours and ulcers with propolis (abstract),
     in the XXV-Th. Apimondia Congress,  Grenoble, France, p.233 (***).

 

 

·        Maftei,I.,  Pãunescu Tamara,  Velescu, G. (1976, 1981, 1990) (Romania) – The apiphytotherapy of some post-radiotherapeutic accidents in the maxillary facial zone,
     in the Second International Symposium on Apitherapy, Bucharest, Romania, 1976,  pp.215-17 (***);
     in “Propolis”, Apimondia Publishing House, III-Rd. edition, 1981,  pp.196-98 (Romanian) (***) and in the IV-Th. edition, 1990,  pp.172-74 (Romanian) (***).

 

 

·        Matsuno, T.;  Chen, C.  and Basnet, P. (1977) (Japan)  –  A tumoricidal and antioxidant compound isolated from an aqueous extract of propolis,
     in Med. Sci. Res. 25,  pp.583 – 584.

 

 

·        Matsuno, Tetsuya (1991) (Japan)  –  ~ “Antitumoral effect of 3 substances isolated from propolis (quercetin, caffeic acid phenethyl ester and a diterpenoid of clerodan)”,
     in the 50-Th. Annual Reunion of the Cancer Japanese Society (cited by Yamamoto, 1996).

 

 

·        Matsuno, Tetsuya (1994)  –  Propolis. Its Pharmacology and Therapeutic Effects.
    
M.P.I. Tokyo, Japan. Edited by Lyon Company. 191 pages.
     Original Japanese Version published in 1984 by Lyon Company (***).

 

 

·        Matsuno Tetsuya; Jung S. K.;  Matsumoto Y.;  Saito M.;  Morikawa J. (1997) (Japan[viii]–  Preferential cytotoxicity to tumor cells of 3,5-diprenyl-4-hydroxycinnamic acid (artepillin C) isolated from propolis,
     in Anticancer Res. Sep; 17(5A),  pp.3565-3568 (***-abstract).[ix]

 

 

·        Pang, J. F.;  Chen, S. S. (1985) (China)  –  Treatment of oral leukoplakia with propolis: report of 45 cases,
     in Chung-Hsi-I-Chieh-Ho-Tsa-Chih., Aug. 5(8),  pp.452-53; 485-86.

 

 

·        Park, Kun Yong[x];  Ikegaki, M.;  Alencar, S.M. (2000) (Brazil)  –  Classificação das própolis brasileira através de suas características fisico-químicaspropriedades biológicas,
     in the First Argentinean Congress on Propolis, Buenos Aires, Argentina, September 1-2, 2000. [xi]

 

 

·        Pascual, C. (1994) (Cuba)  –  Scavenging action of propolis extract against oxygen radicals,
     in J. Ethnopharmacol., Jan; 41(1-2),  pp.9-13 (***-abstract).

 

 

·        Pãun,C., Safta,T., Gîdoiu,Tr., Iercan,E., Olinescu,R., Muntiu,M., Pãunescu Tamara (1976) (Romania) – Experimental investigations of the action of apiphytotherapic preparations on the biological reactivity of radiated animals,
     in the Second International Symposium on Apitherapy, Bucharest, Romania, pp.250-54 (***).

 

 

·        Pãunescu Tamara,  Velescu,G.,  Maftei,I.,  Dragatoiu,A.,  Iosipescu,A.,  Mironescu,M. (1976) (Romania)  –  First results of the apitherapeutic preparations used as adjuvants in the treatment of malignant neoplasm,
     in the Second International Symposium on Apitherapy, Bucharest, Romania,  pp.345-49 (***).

 

 

·        Popova Milena; Bankova Vassya; Chimov, A.; Silva, M. (2002) (Bulgaria, El Salvador)  –  A scientific note on the high toxicity of propolis that comes from Myroxylon balsamum trees,
     in Apidologie 33,  pp.87-88 (***-abstract).

 

 

·        Popovici,N., Oitã,N. (1976, 1978, 1981, 1990) (Romania) – Influence of some extracts of propolis on mitosis in Allium Cepa L. merisistems,
     in the Second International Symposium on Apitherapy, Bucharest, Romania, 1976,  pp.349-52 (***);
     in “Propolis, a remarkable hive product”, Apimondia Publishing House , Bucharest, Romania, 1978,  pp.101-104 (***);
     in “Propolis”, Editura Apimondia, editia a treia, Bucuresti, 1981,  pg.137-40(Rom.) (***) si in editia a IV-a, 1990,  pg.104-08 (Rom.) (***).

 

 

·        Potschinkova, P.A. (1985) (Bulgaria)  –  A case of postradiotherapy proctitis treated with propolis (Romanian),
     in the XXX-Th. Apimondia Congress, Nagoya, Japan,  pp.458-59 (***).

 

 

·        Rao,C.V.,  Desai,D.,  Kaul,B.,  Amin,S.,  Reddy,B.S. (1992)  –  Effect of caffeic acid esters on carcinogen-induced mutagenity and human colon adenocarcinoma cell growth,
     in Chemical and Biological Interactions, 84,  pp.277-90.

 

 

·        Rao,C.V.,  Desai,D.,  Simi,B. et al. (1993)  –  Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon,
     in Cancer Research 53 (18),  pp.4182-4188.

 

 

·        Rao, C. V.; Desai, D.; Rivenson, A.; Simi, B.; Amin, S.; Reddy, B. S. (1995)  –  Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate,
     in Cancer Res, 55(11),  pp.2310-15 (***-abstract). [xii]

 

 

·        Rode,M.,  Herman,O.,  Mirella Rode,  Soba,E. (1979) (Yugoslavia)  –  Application of Apikomplex on alterations in mouth cavity after the radiation therapy of malignant tumours in the head and neck region,
     in the XXVII-Th. Apimondia Congress, Athens, Greece,  pp.499-501 (***).

 

 

·        Rode,M., Voncina,D., Herman,O., Mihelic,A.M. (1983) (Yugoslavia)  –  L’effet de l’ extrait de propolis sur la cicatrisation des plaies (abstract),
     in the XXIX-Th.
Apimondia Congress, Budapest, Hungary, p.177 (***).

 

 

·        Roman,St..,  Palos Elena,  Mateescu Cristina (1989) (Romania) – Propolis-effective way in the treatment of cervico-vaginal erosions, inflammations and dystrophies (Romanian),
     in Apicultura in Romania, 11,  pp.24-26 (***).

 

 

·        Scheller,Stanislaw,  Gazda,G. (1989) (Poland)  –  The ability of ethanolic extract of propolis (EEP) to protect mice against gamma irradiation,
     in Z-Naturforsch. (C), Nov.-Dec. 44(11-12),  pp.1049-52 (***-abstract).

 

 

·        Scheller, Stanislaw; Krol, W.; Swiacik, J.; Owczarek, S.; Gabrys, J.; Shani, J. (1989, 1991)  –  Antitumoral property of ethanolic extract of propolis in mice-bearing Ehrlich carcinoma, as compared to bleomycin,
     in Z Naturforsch (C), 11, 44(11-12), 1989,  pp.1063-65 (***-abstract);
     in Kaal, 1991,  p.27-29 (***). [xiii]

 

 

·        Scheller,Stanislaw.,  Wilczok,T.,  Imielski,S.,  Krol,W., Gabrys,J.,  Shani,J. (1990) (Poland)  –  Free radical scavenging by ethanol extract of propolis,
     in International Journal of Radiation Biology, Mar., 57(3),  pp.461-65 (***-abstract).

 

 

·        Sorkun, K. et al. (1996) (Turkey)  –  An inhibitory effect of propolis on cell division in the root tips of wheat seedlings,
     in the International Conference on Bee Products: Properties, Applications and  Apitherapy, Tel – Aviv, Israel, May 26-30, 1996.

 

 

·        Stojko,R.,  Stojko,A.,  Stojko,J.,  Rezepecka-Stojko,A., Olczyk,D. (1995) (Poland)  –  The use of apitherapeutics in the treatment of leucoplakia,
     in the XXXIV-Th. International Apicultural Congress, Lausanne,  Switzerland, p.140 (***).

 

 

·        Su, Z. Z.; Lin, J.; Grunberger, D.; Fisher, P. B. (1994)  –  Growth suppression and toxicity induced by caffeic acid phenethyl ester (CAPE) in type 5 adenovirus-transformed rat embryo cells correlate directly with transformation progression,
     in Cancer Res, 54(7),  pp.1865-70 (***-abstract). [xiv]

 

 

·        Su, Z. Z.; Lin, J.; Prewett, M.; Goldstein, N. I.; Fisher, P. B.  –  Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogene-transformed rat embryo fibroblast cells,
     in Anticancer Res, 15(5B),  pp.1841-48 (***-abstract). [xv]

 

 

·        Sud’ina, G. F.; Mirzoeva, O. K.; Pushkareva, M. A.; Korshunova, G. A.; Sumbatyan, N. V.; Varfolomeev, S. D. (1993)  –  Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties,
     in FEBS Lett, 329(1-2),  pp.21-24 (***-abstract). [xvi]

 

 

·        Tatefuji, T.;  Izumu, N.;  Ohta, T.;  Arai, Sh.;  Ikeda, M.  and  Kurimoto, M. (1996) (Japan)  –  Isolation and identification of compounds from Brazilian propolis which enhance macrophage spreading and mobility,
     in Biol. Pharm. Bull. 19 (7),  pp.966 -970.

 

 

·        Varanda A. Eliana;  Monti, R.;  Tavares, D.C. (1999) (Brazil)  – Inhibitory effect of propolis and bee venom on the mutagenicity of some direct– and indirect-acting mutagens,
     in Teratog Carcinog Mutagen;19(6),  pp.403-13.

 

 

·        Vasilcã,A.,  Milcu Eugenia (1976, 1978, 1981, 1990) (Romania)  –  Local treatment of chronic ulcers with extract of propolis,
     in the Second International Symposium on Apitherapy, Bucharest, Romania, 1976,  pp.276-79 (***);
     in “Propolis, a remarkable hive product”, Apimondia Publishing House , Bucharest, 1978,  pp.203-207 (***);
     in “Propolis”, Editura Apimondia, Bucuresti, editia a III-a, 1981, pp.245-48 (Rom.) (***) si in editia a IV-a, 1990,  pp.237-40 (Rom.) (***).

 

 

·        Valavichyu,Yu.M.,  Neshukajtene,K.S.,  Valavichene,Ya.V.,  Talutite,E.V. (1975) (U.S.S.R.)  –  Experimental study on the action of bee products on  rats with tumours (Russian),
     in  Liet. T.S.R. Mokslu. Akad. Darb. C.S.S.S.R. 3,  pp.105-10.
     (BS 1976, 37(2) : 2995).

 

 

·        Velikov,P.,  Zanev,M. (1989)  –  The use of propolis preparations in the treatment of radioepithelitis following telegammatherapy of the pharyngeal region,
     in Radiobiol-Radiother., 30(4),  pp.363-67.

 

 

·        Yamada, J.; Tomita, Y. (1996)  –  Antimutagenic activity of caffeic acid and related compounds,
     in Biosci. Biotechnol. Biochem., 60(2),  pp.328-29 (abstract). [xvii]

 

 

·        Yamamoto, Ts. (1997) (Japan)  –  Present State of Basic Studies on Propolis in Japan,
     in Apiacta XXXII, # 2,  pp.51-64 (***).

 

 

 



[i] ANTIMETASTATIC ACTIVITY OF PROPOLIS, CAFFEIC ACID PHENETHYL ESTER AND CAFFEIC ACID AGAINST MAMMARY CARCINOMA OF CBA MICE

 

312        I. BASIC, N. ORSOLIC, A. BRBOT-SARANOVIC,   Z. TADIC, 
                                              D. SULIMANOVIC

                         (CROATIA)

 

We have studied the antimetastatic efficacy of caffeic acid phenethyl ester (CAPE), a propolis-derived compound and compared it with the antimetastatic effect of either water-soluble derivatives of propolis (WSDP) or caffeic acid (CA).  The tumor was a transplantable mammary carcinoma (MCA) of spontaneous origin, weakly immunogenic, to a syngeneic CBA mouse.  Metastases in the lung were generated by injecting 2 x 105 viable tumor cells intravenously.  Tested compounds were given per os before or after tumor cell inoculation, the dose comprises 12.5 mg/mouse of either CAPE or CA, and 50 mg/mouse of WSDP, respectively.  Both the preventive and the curative therapy significantly reduced the number of tumor nodules in the lung of mice.  The antimetastatic effectiveness of both WSDP and CAPE was equally high and also higher than that of CA.  Two approaches for testing the possible mode of antimetastatic activity in the lungs were proposed: a modulation of immune reaction of recipients or an induction of apoptosis during the formation of metastatic nodules.  Changes in several immunological parameters, such as the response of lymphocytes to polyclonal mitogens in vitro, the production of tumor necrosis factor (a (TNF a) by lymphoid cells in vitro and the rosette formation of lymphoid cells with SRBC, correlated well with the antimetastatic properties of the tested compounds.  A direct relationship was also found between the antimetastatic activity of the compounds studied and the induction of apoptosis.

                                                                                                p.119

 

 

[ii]

Kittharz – die antibiotische  Alternative

von Walter Binder (Naturheilpraxis 5/79)

 

 

Das Kittharz der Bienen hat nach Auffassung zahlreicher Forscher in aller Welt, insbesondere in Rumänien, der UdSSR, den USA und in Dänemark eine hervorragende antibiotische Wirkung.  Eine stattliche Kasuistik untermauert diese Meinung Zunächst muß festgestellt werden, daß die Lebensform Biene, so wie sie heute in Erscheinung tritt, seit 42 Millionen Jahren existiert und eine abgrundtiefe Zahl anderer Insektenformen überlebt hat.  Das hat sicher seinen Grund.  Die ihr zugedachte Rolle, einmal die Bestäubung der Blüten, zum anderen die Verbreitung verschiedenster Pflanzensamen, hat ja auf die Pflanzenwelt eine mutagen-dynamisierende Wirkung und hilft ihren Bestand sichern.

Wenn eine bestimmte Tierart in unserer Biosphäre überlebt, dann muß ihr Organismus eine Reihe von wirksamen Programmen haben, die im Notfall rechtzeitig einsetzen.  Unter den entscheidenden Eigenschaften ist wohl die wichtigste jene, wirksame Abwehrmechanismen gegen Mikro- wie auch Makro-aggressoren zu besitzen.  Gerade diese Eigenschaften, eine universelle bakterizide und eine bakteriostatische Sekretproduktion, besitzen die Bienen.  Daß z. B. in einem Bienenkorb von, Kubikmeter Volumen, ohne endemische Einbrüche 50.000 bis 60.000 Insekten auf engsten Raum und unter feuchttropischen Klima existieren, erscheint wie ein Wunder.  Deshalb ist es auch einleuchtend, daß alle Produkte, die mit dem Speichel der Biene verarbeitet werden, von Bakterien, Viren und Pilzen nicht angegriffen werden können.

Den-Kittharz (auch Propolis genannt) besorgen die Kittharzbienen im Spätsommer und Herbst (August bis Oktober), wenn durch starke Sonneneinstrahlung.die Bäume harzen und das Harz flüssig genug ist für den Transport.  Die Harzpartikel werden mit dem enzymreichen Speichel löslich gemacht und in den Kitthöschen deponiert. Im Stock übernehmen andere Arbeitsbienen den Kittharz, speicheiln ihn erneut ein und verschließen damit alle Ritzen und Spalten in der Stockwandung.  Auch das Flugloch wird mit Kittharz eingefaßt.  Es kommt den Bienen darauf an, sich für die kommenden Wintermonate vor Feuchtigkeit, Kälte, Zugluft, und, was das allerwichtigste ist, vor Mikro- und Makroorganismen zu schützen.

Unter anderem verwenden die Bienen den Kittharz auch zur Mumifizierung größerer Tiere, die nicht mehr aus dem Stock entfernt werden können, z.-B. kleine Eidechsen, größere Käfer usw.  Der Kittharz hat eine hervorragende konservierende Wirkung, und verhindert die bakterielle Zersetzung.  Befallen verschiedene Mikroorganismen z. B. der Pilz Aspergillus flavus die Bienenbrut, so werden die Pilzverseuchten Strecklarven sofort mit Kittharz bedeckt und damit auch die resistenten Sporen unschädlich gemacht.

 

 

Ersatz für Penicillin

 

Nun zum medizinischen Teil : Mikrobiologische Untersuchungen mit Tuberkelbazillen wurden bereits in Dänemark (1948 ) gemacht.  Dabei hat sich ein wäßriger Extrakt aus Propolis gegen die an sich resistenten Bakterien als wirksam erwiesen.  Später wurden erstmals an der TU in Kopenhagen Propolisextrakte an 30 verschiedenen Mikroorganismen angewandt und eine wachstumshemmende Wirkung beobachtet. 1968 untersuchten die dänischen Forscher Jens Hoiriis Nielsen und Hans Erik Christensen die Wirksamkeit von äthanolischen Propolisauszug gegen Schmarotzerpilze.  Das Ergebnis verlief für alle Pilze tödlich.  In einem Parallelversuch wurden 15 Propolisproben gegen 39 Bakterienstämme und 20 Schmarotzerpilzen angewandt.  Davon wurden 24 Bakterienstämme in ihrem Wachstum gehemmt und alle 20 Pilzarten getötet.  Die rumänischen Wissenschaftler.  A. Derevici und A. Popesku fanden heraus, daß-Propolisextrakte auf Enterococcen eine absolut tödliche Wirkung haben, jedoch nicht auf Staphylococcen.  Am staatlichen Forschungsinstitut für Medizin in Kazan (UdSSR) (1963) wurden  50 Tuberkulosepatienten mit einer propolishaltigen Ernährung kurmäßig versorgt.  Das Resultat war außerordentlich zufriedenstellend.  Todorov, ein bekannter bulgarischer Wissenschaftler, entdeckte die günstige Wirkung von Propolisextrakt auf das vegetative Nervensystem und beobachtete eine Gefäßerweiterung im mittleren Arterienbereich.  Das wissenschaftliche Institut für Röntgenologie, Radiologie und Onkologie in Kiew (UdSSR) hat nach Strahlenverbrennungen die Haut mit Propolissalben erfolgreich behandeln können.  Am staatlichen Laboratorium in Baschkirien (UdSSR) veröffentlichte der Wissenschaftler Tjeannitsjev einen profunden Bericht über die spezifischen Eigenschaften des Propolis gegenüber der Abwehr und wies auch eine hämatogene Wirkung nach.  Seine Forschungsergebnisse belegte er mit 2000 Versuchen an Patienten.

 

Nach seiner statistischen Studien der Kasuistik sind die größten Erfolge bei Infektionen des Nasen-Rachenraumes zu verzeichnen.  Es folgen Rhinitis, Sinusitis, Otitis media, Conjunktivitis, verschiedene Influenzaformen, unklare grippöse Infekte mit bronchitischer, Tendenz, Pyelonephritis, Cystitis, Prostatitis, Colitis, alle Enteritiden, Gastritis, Ulcus Duodenum sowie Magengeschwüre.

 

Extern:  Ekzeme vor allem Mykosen, Ulcus cruris, nekrotische Gewebsprozesse, Brand, Karbunkel, und auch Phlegmonöse Entartungen.

 

Es läßt sich ohne Übertreibung sagen, daß Propolis die allmählich stumpf werdende Penicillinwaffe ersetzen könnte.  Vor allem die einmaligen Ergebnisse von Z. G. Tjeannitsjev geben zu denken.  Er hebt im besonderen hervor, daß die Phagozytenzahl merklich ansteigt, die Emigrationsgeschwindigkeit der Leukozyten beträchtlich zunimmt und im serologischen Test die Antikörper erhöht waren.  Ihre Reaktionsgeschwindigkeit mit dem Antigen scheint vergrößert.  Außerdem sein die fibrinolytischen Faktoren vermehrt und die roten Blutkörperchen zahlreicher. Er konnte auch an Hand seiner Kasuistik nachweisen, daß die Zahl der Koagulopathien spürbar sank.

 

Resümee:              Die Wirkung.von Kittharz und seine komplexe Einflußnahme auf den Organismus ist um so rätselhafter, wenn man die chemische Inhaltsanalyse dazu vergleicht: 55 % Harz und Balsam, 30% Wachs, 10% flüchtige Öle, 5% Pollen, und als mineralische Verbrennungsrückstände: Calcium, Aluminium, Vanadium, Mangan und Silicium.

Einerseits scheint es auf das erythropoetische System eine gewisse Anstoßwirkung zu haben, das gesamte RES zu aktivieren, die fibrinolytische Entstehung in der Leber und seine hämatogene Entfaltung zu begünstigen, auf die Bakterienbesiedelung des enteralen Abschnittes selektpositiv einzuwirken, andererseits den adrenerg bedingten Hochdruck im  mittleren Arterienbereich und Arteriolensystem durch sympathatikolytische Einflüsse zu senken.  Fraglich ist auch eine anabol-hormonale Wirkung.  Extern fördert Propolis die Granulierung und Epithelisierung von Wunden, Ekzemen und gutartigen Hautentartungen.

 

 

[iii] [26]    El-Ghazaly, M. A., & Khayyal, M. T. (1995). The use of aqueous

propolis extract against radiation-induced damage. Drugs Exp Clin Res,

21(6), 229-36, Whole body exposure to gamma radiation has been

experimentally shown to exaggerate inflammatory responses and to enhance

the release of mediators. A thirteen per cent aqueous extract of propolis

(bee glue) was previously shown to have potent antiinflammatory activity.

The present study was carried out to show whether the extract could

influence the exaggerated inflammatory response in irradiated animals. Rats

were exposed to acute (2 and 6 Gy) & fractionated (1 Gy/week) doses of

gamma ionizing radiation. Treatment with the aqueous extract orally (5

ml/kg) before and after radiation exposure markedly reduced the exaggerated

paw oedema response to carrageenan. In the acute phase of adjuvant-induced

arthritis, exposure to ionizing radiation caused an increase in serum acid

phosphatase level. Malondialdehyde concentration in plasma and superoxide

dismutase activity in blood significantly increased. Treatment with aqueous

propolis extract prior to irradiation reduced malondialdehyde concentration

in plasma and normalized the serum acid phosphatase level. The extract

stimulated the release of superoxide dismutase enzyme. Aqueous propolis

extract could possibly be of therapeutic value in protecting against

inflammatory responses induced by gamma radiation.

[iv] HASHIMOTO, Takaharu; AGA, Hajime;
TABUCHI, Akihiko; SHIBUYA, Takashi; CHAEN,
Hiroto; FUKUDA, Shigeharu; KURIMOTO, Masashi (1998) (Japan)  –  Anti-Helicobacter
pylori
compounds in Brazilian propolis. Natural Medicins 2(),  pp.518-520.

An ethanol extract from Brazilian propolis has antibacterial activity on
Helicobacter pylori, from which two active fractions were obtained by silica
gel column chromatography. From one fraction, an anti-H. pylori compound was
isolated which was identified as 4-hydroxycinnamic acid (p-coumaric acid:1),
and from the other fraction, 3-prenyl-4-hydroxy-cinnamic acid,
3-prenyl-4-dihydrocinnamoloxycinnamic acid, and
3,5-diprenyl-4-hydroxycinnamic acid were isolated, whose anti-H. pylori
activities expressed as the minimal inhibitory concentration (MIC) in mg/ml,
were 15.6-31.3, 62.5, 125, and 250, respectively. 4-Hydroxycinnamic acid
derivatives are likely to be major anti-H. pylori compounds in Brazilian
propolis.

 

[v] Jaiswal, A. K.; Venugopal, R.; Mucha, J.; Carothers, A. M.;  Grunberger, D. (1997)  –  Caffeic acid phenethyl ester stimulates human antioxidant response element-mediated expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene,
            in Cancer Res, 57(3),  pp.440-46 (***-abstract).

Caffeic acid phenethyl ester (CAPE) is a phenolic antioxidant derived from the propolis of honeybee hives. CAPE was shown to inhibit the formation of intracellular hydrogen peroxide and oxidized bases in DNA of 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated HeLa cells and was also found to induce a redox change that correlated with differential growth effects in transformed cells but not the nontumorigenic parental ones. Mediated via the electrophile or human antioxidant response element (hARE), induction of the expression of NAD(P)H quinone oxidoreductase (NQO1) and glutathione S-transferase Ya subunit genes by certain phenolic antioxidants has been correlated with the chemopreventive properties of these agents. Here, we determined by Northern analysis that CAPE treatment of hepatoma cells stimulates NQO1 gene expression in cultured human hepatoma cells (HepG2), and we characterized the effects of CAPE treatment on the expression of a reporter gene either containing or lacking the hARE or carrying a mutant version of this element in rodent hepatoma (Hepa-1) transfectants. A dose-dependent transactivation of human hARE-mediated chloramphenicol acetyltransferase (cat) gene expression was observed upon treatments of the Hepa-1 transfectants with TPA, a known inducer, as well as with CAPE. The combined treatments resulted in an apparent additive stimulation of the reporter expression. To learn whether this activation of cat gene expression was effected by protein kinase C in CAPE-treated cells, a comparison was made of cat gene activity after addition of calphostin, a protein kinase C inhibitor. Calphostin reduced the cat gene induction by TPA but not by CAPE, suggesting that stimulation of gene expression in this system by these agents proceeds via distinct mechanisms. Band-shift experiments to examine binding of transactivator proteins from nuclear extracts of treated and untreated cells to a hARE DNA probe showed that TPA exposure increased the binding level. In contrast, binding of factors to this probe was inhibited after either in vivo treatment of cells with CAPE or in vitro addition of this compound to the nuclear extract. In view of the clear stimulation by CAPE of gene expression mediated by hARE, possible explanations of this result are discussed.

 

[vi] Lambert, Priscila (1999) (Brazil)  – Pesquisa mostra que resina produzida pelas abelhas impede o crescimento de células cancerígenas. Própolis pode proteger corpo de tumores,
          in Folha de São Paulo, 12 de Julho de 1999.

Investigación muestra que la resina producida por las abejas impide el crecimiento de células cancerígenas.

El Própoleo puede proteger al cuerpo de tumores.

PRISCILA LAMBERT

de un Reportage Local

 

El propoleo, aquella resina que las abejas producen para proteger la colmena de invasores, también puede tener propiedades que protegen al cuerpo humano de “invasores”.

            Un estudio realizado en Brasil recientemente demostró que determinados tipos de propoleos impedirían el crecimiento de células cancerígenas en estúdios de laboratorio. La investigación fué realizada por el bioquímico Yong Kun Park, profesor titular de la Facultad de Ingenieria de Alimentos de Unicamp (Universidade Estadual de Campinas).

            El ya había sido director en una tesis que concluyó que ciertos tipos de propoleos inhiben la acción de la bacteria Streptococcus mutans, causadora de carie dentaria (lea el texto en esta página).

            El profesor viene estudiando la actividad del propoleo desde 1990. Fueron analizadas 400 muestras recolectadas en todas las regiones del país.

 

Muestras

            La primer conclución, despues de un test de cromatografia (una especie de fotografía de los compuestos químicos), fue la de que, dentro de las 400 muestras, 12 eran diferentes entre sí. O sea, existen por lo menos 12 tipos de propoleos en Brasil, que varían de coloración y composición.

            Solamente en la región sur, Park descubrió siete tipos diferentes de resina. “El país tiene una biodiversidad muy rica, lo que explica las variaciones de propoleos. En paises europeos o en EUA, las resinas de las abejas son todas iguales”, dice el profesor. “Cada tipo de propoleo brasilero tiene una propiedad antimicrobiana o antibiótica diferente”.

            En su estúdio, los 12 tipos de propoleos fueron colocados en contacto con diferentes células cancerosas –del intestino, riñon, mamas, nariz y faringe.

 

Tiempo

            Despues de dos semanas –tiempo sufuciente para que las células se repordujeran y crecieran-, diez muestras habían presentado, en diferentes grados, no solo la inhibición de crecimiento, sino la destrucción parcial de las células.

            La muestra que presentó el mejor resultado fué un tipo de propoleo de Bahia (BA-8), que redujo las celulas de cancer nasofaríngeo en 97% y de mama en 96%, entre otros (vea quadro al lado).

            El método de cálculo de inhibición de tumores utilizado en el estudio tuvo como base de comparación los resultados obtenidos por la droga Etoposide, la más fuerte existente en el mercado para combatír el cancer. Ese método fué desarrollado por el Instituto Nacional del Cancer de los EUA.

            Los resultados presentados en el estúdio de Park fueron confirmados en un test realizado por investigadores norteamericanos de la Universidad de Carolina del Norte (EUA).

            La investigación rindió al profesor Park una invitación para pasar el próximo mes como profesor-visitante de la universidad norteamericana, donde comenzará nuevos estudios, ahora para descubrir cuales son los compuestos químicos presentes en el propoleo y responsables por la acción anticancerígena.

 

[vii] Lambert, Priscila (1999) (Brazil)  – Própolis puede proteger del sol,
                in Folha de São Paulo, 12 de Julho de 1999.

Outra propiedad atribuída al propoleo es la de filtrar los rayos ultravioletas tipo B.

            La farmacéutica Ana Luíza Mori, responsable por la farmacia universitaria de la Facultad de Ciencias Farmacéuticas de la USP, desarrollo una monografía de maestrado sobre esa acción del propoleo.

            Ella utilizó extractos de propoleos de diferentes regiones del país y del mundo para crear bases cosméticas, que fueron sometidas a un aparato que mide el grado de absorción de rayos ultravioletas.

            Como resultado, Ana Luíza obtuvo factores de protección de los rayos UVB que variaron de 1 (protección casi nula) hasta 8, en la muestra de propoleo de Pensilvania (EUA).

            “La utilización del propoleo como medicamento fitoterápico es complicada, porque la composición de la resina varía de acuerdo com el suelo, la vegetación y la época del año”, dice.

 

[viii] National Institute of Health, Tokyo, Japan.

 

[ix] A tumoricidal substance was isolated from Brazilian propolis as guided by cytotoxicity assay on HuH 13 (human hepatocellular carcinoma) cell and was characterized to be 3-[4-hydroxy-3,5-bis (3-methyl-2-butenyl)

phenyl]-2-propenoic acid (3,5-diprenyl-4-hydroxycinnamic acid (artepillin

C)). It exhibited preferential cytotoxicity to tumor cells cultured in

vitro. The cytotoxicity observed seemed to be partly attributable to

apoptosis-like DNA fragmentation. The compound showed anti-tumor activity more effective than that of 5-fluorouracil to transplantable human tumor cell lines when tested on histoculture drug response assay system.

 

[x] Universidade Estadual de Campinas – UNICAMP, Faculdade de Engenharia de Alimentos, Caixa Postal 6177, CEP 13081 – 970, Campinas – SP, Fone: 55-19-788-7055, Fax: 55-19-788-7890. Email: ykpark@fea.unicamp.br

 

[xi] We have collected 500 propolis samples which were collected by Africanized Apis mellifera in Southern, Southeastern, Central western, and Northeastern Brazil. The respective samples were extracted with ethanol. The ethanolic extracts of propolis (EEP) were analyzed by physicochemical methods such as appearance of EEP, measurement of absorption spectra by UV-spectrophotometry, reversed phase-thin layer chromatography (RP-HPTLC), reversed phase high performance liquid chromatography (RP-HPLC) and then the EEPs were evaluated their physiological activities such as antioxidant activity, antimicrobial activity, assay of cytotoxic activity to cancer cells, and HIV-growth inhibition assays. In accordance with results of EEP appearance, UV-absorption spectra, RP-HPTLC, and RP-HPLC, the propolis were classified as 12 groups. Among 12 groups of propolis, five groups of propolis were collected from Southern Brazil, whereas six groups of propolis were collected from Northeastern Brazil. Furthermore, one group of propolis was found in Southeastern Brazil. It was found that the variety of propolis is depending on plant ecology. Although rarely exceptional propolis was found in spite of geographic locations, these propolis were not included in this study. Physiological activities for 12 groups of propolis were also variables, depending on geographical location. This is due to fact that the compositions of propolis are depending on the compositions in plants.

 

[xii] Rao, C. V.; Desai, D.; Rivenson, A.; Simi, B.; Amin, S.; Reddy, B. S. (1995)  –  Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate,
            in Cancer Res, 55(11),  pp.2310-15 (abstract).

Previous studies from this laboratory have established that caffeic acid esters present in propolis, a natural resin produced by honey bees, are potent inhibitors of human colon adenocarcinoma cell growth, carcinogen-induced biochemical changes, and preneoplastic lesions in the rat colon. The present study was designed to investigate the chemopreventive action of dietary phenylethyl-3-methylcaffeate (PEMC) on azoxymethane-induced colon carcinogenesis and to examine the modulating effect of PEMC on phosphatidylinositol-specific phospholipase C (PI-PLC), phospholipase A2, lipoxygenase (LOX), and cyclooxygenase activities in the colonic mucosa and tumor tissues in male F344 rats. At 5 weeks of age, groups of rats were fed the control (modified AIN-76A) diet, or a diet containing 750 ppm of PEMC. At 7 weeks of age, all animals except those in the vehicle (normal saline)-treated groups were given 2 weekly s.c. injections of azoxymethane at a dose rate of 15 mg/kg body weight/week. All groups were maintained on their respective dietary regimen until the termination of the experiment 52 weeks after the carcinogen treatment. Colonic tumors were evaluated histopathologically. Both colonic mucosa and tumors were analyzed for PI-PLC, phospholipase A2, cyclooxygenase, and LOX activities. The results indicate that dietary administration of PEMC significantly inhibited the incidence and multiplicity of invasive, noninvasive, and total (invasive plus noninvasive) adenocarcinomas of the colon (P < 0.05-0.004). Dietary PEMC also suppressed the colon tumor volume by 43% compared to the control diet. Animals fed the PEMC diet showed significantly decreased activities of colonic mucosal and tumor PI-PLC (about 50%), but PEMC diet had no effect on phospholipase A2. The production of 5(S)-, 8(S)-, 12(S)-, and 15(S)- hydroxyeicosatetraenoic acids via the LOX pathway from arachidonic acid was reduced in colonic mucosa and tumors (30-60%) of animals fed the PEMC diet as compared to control diet. PEMC had no effect on the formation of colonic mucosal cyclooxygenase metabolites but inhibited the formation in colonic tumors by 15-30%. The precise mechanism by which PEMC inhibits colon tumorigenesis remains to be elucidated. It is likely that the chemopreventive action may be related, at least in part, to the modulation of PI-PLC-dependent signal transduction and LOX- mediated arachidonic acid metabolism.

 

[xiii] Scheller, Stanislaw; Krol, W.; Swiacik, J.; Owczarek, S.; Gabrys, J.; Shani, J. (1989, 1991)  –  Antitumoral property of ethanolic extract of propolis in mice-bearing Ehrlich carcinoma, as compared to bleomycin,
            in Z Naturforsch (C), 11, 44(11-12), 1989,  pp.1063-65 (abstract);
            in Kaal, 1991,  p.27-29 (***).


Antitumoral effect of ethanolic extract of propolis (EEP) was demonstrated in mature mice-bearing Ehrlich carcinoma. Survival rate after EEP treatment was compared to that of bleomycin, given alone or in combination every two days for 36 days and followed up for 14 additional days. The survival rate at 50 days was 55% after EEP and 40% after bleomycin, while all the mice-treated with EEP + bleomycin combination demonstrated shorter survival than the controls. It is concluded that while the in vivo activity of bleomycin is reduced in the presence of cytochrome-C-reductase inhibitors (like some of the EEP components are), the antitumoral property of EEP in the tumored animal model studied is significant and lasting.

 

[xiv] Su, Z. Z.; Lin, J.; Grunberger, D.; Fisher, P. B. (1994)  –  Growth suppression and toxicity induced by caffeic acid phenethyl ester (CAPE) in type 5 adenovirus-transformed rat embryo cells correlate directly with transformation progression,
            in Cancer Res, 54(7),  pp.1865-70 (abstract).

The active component of the honeybee hive product propolis, caffeic acid phenethyl ester (CAPE), induces a selective growth suppressive and toxic effect toward cloned rat embryo fibroblast cells transformed by adenovirus type 5 (Ad5) or the Ad5 E1A transforming gene versus untransformed cloned rat embryo fibroblast cells (Z-z.
Su et al., Mol. Carcinog., 4: 231-242, 1991). The present study was conducted to determine whether CAPE-induced growth suppression/toxicity was a direct result of expression of the Ad5 E1A and E1B transforming genes or a consequence of the action of these genes resulting in the transformed state. For this investigation we used somatic cell hybrids and 5- azacytidine-treated Ad5-transformed rat embryo cells that display different stages of expression of the transformed phenotype. This series of cell lines has permitted us to determine whether expression of the transformed state and the stage of transformation progression regulates CAPE sensitivity. Evidence is presented indicating that sensitivity to CAPE is directly determined by the state of expression of the transformed progression phenotype, as opposed to simply the expression of the Ad5 E1A and E1B transforming genes. These results provide further evidence that CAPE may represent a unique compound that can specifically target progressed transformed cells for growth suppression and toxicity. An understanding of the mechanism underlying this selective effect of CAPE could result in the identification of important biochemical pathways mediating cellular transformation and progression of the transformed state.

 

[xv] Su, Z. Z.; Lin, J.; Prewett, M.; Goldstein, N. I.; Fisher, P. B.  –  Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogene-transformed rat embryo fibroblast cells,
            in Anticancer Res, 15(5B),  pp.1841-8 (abstract).

The active component of the folk medicine propolis, caffeic acid phenethyl ester (CAPE), displays selective toxicity toward cloned rat embryo fibroblast (CREF) cells transformed by a spectrum of diverse acting oncogenes. Identification of the mode of action of CAPE should provide useful information for possible applications of this compound for cancer therapy. The present study uses a series of oncogene transformed, oncogene-reverted and CAPE-resistant oncogene transformed CREF cells to investigate the mechanism underlying the increased sensitivity of transformed cells to CAPE. A direct relationship exists between the cytotoxic effects of CAPE and the induction of DNA fragmentation and apoptosis. DNA degradation into nucleosomal fragments and apoptotic shifts in DNA cell cycle profiles occur in CAPE-treated CREF cells transformed by wild-type 5 adenovirus (Ad5), a mutant Ad5 (H5hr1), the wild-type Ad5 E1A transforming gene, v-src, Ha-ras and the human papilloma virus type 18 transforming genes (HPV-18). In contrast, untransformed CREF cells, human fibroblast expression library-induced morphological revertants of Ad5- and v-src-transformed CREF cells, and Krev-1 expressing revertant Ha-ras-transformed CREF cells are resistant to CAPE-induced toxicity and apoptosis. Similarly, mutant Ad5- transformed CREF cells selected by step-wise growth in increasing concentrations of CAPE are resistant to growth inhibition and apoptosis induced by CAPE. These findings indicate that expression of the transformed phenotype by rodent cells evokes sensitivity to CAPE induced toxicity through apoptosis. The acquisition of CAPE sensitivity in rodent cells is independent of the mode of action of the oncogenic agent. CAPE may prove useful as an antiproliferative agent in cancer cells transformed by mechanistically diverse acting oncogenes.

 

[xvi] Sud’ina, G. F.; Mirzoeva, O. K.; Pushkareva, M. A.; Korshunova, G. A.; Sumbatyan, N. V.; Varfolomeev, S. D. (1993)  –  Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties,
            in FEBS Lett, 329(1-2),  pp.21-24 (abstract).

Caffeic acid phenethyl ester, an active component of propolis extract, inhibits 5-lipoxygenase in the micromolar concentration range. The inhibition is of an uncompetitive type, i.e. the inhibitor binds to the enzyme-substrate complex but not to the free enzyme. Caffeic acid phenethyl ester also exhibits antioxidant properties. At a concentration of 10 microM, it completely blocks production of reactive oxygen species in human neutrophils and the xanthine/xanthine oxidase system.

 

[xvii] Yamada, J.; Tomita, Y. (1996)  –  Antimutagenic activity of caffeic acid and related compounds,
            in Biosci. Biotechnol. Biochem., 60(2),  pp.328-29 (abstract).

Effects of caffeic acid and chlorogenic acid on mutagenicity were studied using the Salmonella typhimurium system. These compounds had inhibitory effects on the mutagenicity of Trp-P-1 and Glu-P-2. Caffeic acid completely eliminated the mutagenicity induced by activated Glu-P- 2. Some compounds analogous to caffeic acid, such as cinnamic acid, coumaric acid, and ferulic acid, also significantly decreased the mutagenicity of Glu-P-2.

 

References on the use of Bee venom against cancer:

  • *** (1999) –  Abstract of Papers – Pacific Northwest Apitherapy Conference, Vancouver, Canada, June,  12-14, 1998.
         Apitherapy Education Service – Apitronic Services, pp.25 (***).

 

 

  • Bašic,I., Curic,S.,  Tadic,Z.,  Oršolic,N.,  Sulimanovic,D. (1995) (Croatia)  –  Antimetastatic activity of bee venom and water soluble derivatives of propolis in mice,
         in the XXXIV-Th. Apimondia Congress, Lausanne, Switzerland,  135-136 (***-abstract).

 

 

  • Beck, F. Bodog (1935, 1997) (USA) –  Bee Venom Therapy. Bee Venom, Its Nature, and its effect on Arthritic and Rheumatoid Conditions.
         Appleton-Century Co., Incorporated.
    New York. London, 1935 238 pp.; references, bibliography and two indices (***);
         Health Resources Press, 1997 (under the name: The Bible of Bee Venom Therapy).

 

 

  • Belliveau, J. (1992) –  The effectiveness of bee venom and adjuvant induced colon cancer of the rats,
         in the Second American Apitherapy Society Conference, Boston, USA.

 

 

  • Bomalaski, J. S.[i] (1995) –  Phospholipase A2-activating protein induces the synthesis of IL-1 and TNF in human monocytes,
         in J Immunol., Apr 15;154(8),  4027-31 (***-abstract). [ii]

 

 

  • Derevici Adelina, Popescu,Al.,  Nuca Olga (1967)  –  Methode d’identification du venin d’abeille par l’etude de ses propriétés antibiotiques, proteolytiques, hemolytiques et anticoagulantes,
         in Bulletin Apicole I (1),  63-73.

 

 

  • Forster, K. A.(1969) (Germany) –  Chemistry, pharmacology and therapeutically effectiveness of bee venom,
         in the XXII-Nd. Apimondia Congress, Munich, Germany,  405-407 (***).

 

 

  • Fukazawa, K. (1985) (Japan) –  Acuponcture avec abeilles au Japon,
         in the XXX-Th. Apimondia Congress, Nagoya, Japan,  456-459 (***). [iii]

 

 

  • Gerst J. E.; Salomon, Y. [1] (1987) (Israel)  –  Inhibition by melittin and fluphenazine of melanotropin receptor function and adenylate cyclase in M2R melanoma cell membranes,
         in Endocrinology Nov;121(5),  1766-1772 (***). [iv]

 

 

  • Ginsberg, N. J.; Dauer, M.;  Slotta, K. H. (1968)  –  Melittin used as a protective agent against X-irradiation,
         in Nature 220,  1334.

 

 

  • Higuchi, M. [v] (1992) –  Damage to mitochondrial respiration chain is related to phospholipase A2 activation caused by tumor necrosis factor (TNF),
         in J Immunother Jul;12(1),  41-49. [vi]

 

 

  • Kim Christopher, M.-M. (1997) –  Apitherapy (bee venom therapy): A literature review, Part 1.,
         in Bee Informed, volume 4, no. 3, Autumn,  4-5; 20 (***).

 

 

  • Kim Christopher, M.-M. (1998) –  Bee venom therapy: A literature review, Part II.,
         in Bee Informed, volume 4, no. 4, Winter,  5-10 (***).

 

 

  • Krylov, N. Vasily (1995) (Russia) –  Bee venom: properties, production, usage (Russian).
         Nizhny Novgorod. Lobachevsky University. 224 pp., illustrations;
         ISBN -5-85746-076-X. (***).

 

 

  • Orlov, B. N.; Khomutov, A. E.;  Korneva, N. V.;  Nekrasova, L. A.;  Iaghin, V. V. (1987) (USSR)  –  New aspects in the experimental study on bee venom,
         in the XXXI-St. Apimondia Congress, Warsaw, Poland,  473 (***-abstract).

 

 

  • Saini, S. S.; Chopra, A. K.;  Peterson, J. W.[vii] (1999) (USA)  – Melittin activates endogenous phospholipase D during cytolysis of human monocytic leukemia cells,
         in Toxicon 1999 Nov; 37(11),  1605-19 (***). [viii]

 

 

  • Sharma, S. V. [ix] (1992) (USA) –  Melittin resistance: a counterselection for ras transformation,
         in Oncogene, Feb;7(2),  193-201. [x]

 

 

  • Shipman, W. H.; Cole, L. J. (1967)  –  Increased resistance of mice to X-irradiation after injection of bee venom,
         in Nature 215,  311-312.

 

 

  • Varanda A. Eliana; Takahashi, S. Catarina;  Soares A. E. E. (1989) (Brazil)  –  Honeybee venom as a radioprotective agent in Wistar rats irradiated with gamma rays,
         in the XXXII-Nd. Apimondia Congress, Rio de Janeiro, Brazil,  546 (***-abstract).

 

 

  • Varanda A. Eliana; Monti, R.;  Tavares, D.C. (1999) (Brazil)  – Inhibitory effect of propolis and bee venom on the mutagenicity of some direct– and indirect-acting mutagens,
         in Teratog Carcinog Mutagen;19(6),  403-13.

 

 

  • Winder, D.; Gunzburg, W. H.;  Erfle, V.;  Salmons, B. [xi](1998) (Germany)  –  Expression of antimicrobial peptides has an antitumour effect in human cells,
         in Biochem Biophys Res Commun Jan 26;242(3),  608-612 (***). [xii]

 

 

  • Yoannovitch, G. and Chahovitch, X. (1932) –  Le traitement des tumeurs par le venin des abeilles (see also p.35-36 in Bodog Beck’s book, 1935),
         in Acad. De Méd. Par., Juin.

 

 

[1]Gerst,J.E.,  Salomon,Y: Department of Hormone Research, Weizmann Institute of Science, Rehovot, Israel.

 

[i] Bomalaski’s Adress  – Medical College of Pennsylvania, Philadelphia 19129, USA.

[ii] Bomalaski, J. S. (1995)  –  Phospholipase A2-activating protein induces the synthesis of IL-1 and TNF in human monocytes,
            in J Immunol., Apr 15;154(8),  pp.4027-31.

Phospholipase A2-activating protein (PLAP) is an important mediator of eicosanoid generation. PLAP can also be found in high concentrations in synovial fluid from patients with rheumatoid arthritis, and injection of PLAP into animal joints results in an inflammatory, rheumatoid-like lesion. We have demonstrated previously that TNF-alpha and IL-1 beta stimulate formation of PLAP before phospholipase A2 (PLA2) enzyme activation and production of eicosanoids. To further explore the mechanisms found in the inflammatory response, we examined the ability of PLAP to stimulate release of TNF and IL-1 from human peripheral blood monocytes. TNF and IL-1 protein levels were measured by ELISA, and IL-1 and TNF mRNA were determined by Northern blotting. PLAP, PLAP peptide, and melittin, a bee venom PLA2 activator with homology with PLAP, all increased IL-1 and TNF production in a time- and dose-dependent manner. Heat-denatured PLAP and actin (an irrelevant protein) failed to exert this effect. PLAP stimulation of TNF and IL-1 could be enhanced with co-treatment of cells with free fatty acids, such as arachidonic or linoleic acid, but it was not blocked completely by PLA2 inhibitors. These results demonstrate not only that synthesis of PLAP can be stimulated by cytokines, but also that PLAP may regulate cytokine synthesis and thus perpetuate an immune or inflammatory response.

[iii]

ACUPONCTURE AVEC ABEILLES AU JAPON

 

FUKAZAWA, K.

JAPON

 

L’acuponcture avec abeilles a débuté il y a 65 ans, en 1920, par des apiculteurs enthousiastes.  Tout a commencé quand un apiculteur âgé qui était paralysé a essayé de capturer un essaim d’abeilles dans son jardin.  Il est tombé et a été piqué par les abeilles sur tout son corps.  Les nouvelles de sa miraculeuse guérison se sont répandues et ont servi de bases aux méthodes actuelles.

Autrefois, pour pratiquer l’acuponcture avec abeilles, il y avait besoin seulement d’une demande faite auprès des autorités locales.  Quand en 1949 on a modifié les lois, on a adopté un système nationale d’examen ; pour pratiquer l’acuponcture avec abeilles, il y avait besoin de recevoir une approbation sans examen, par un arrangement de faveur avec l’état.  Plusieurs personnes qui pratiquaient l’acuponcture et qui sont les témoins de la pratique de l’acuponcture sans approbation vivent encore ; certains pratiquent l’acuponcture à la suite de l’approbation donnée par la Police Métropolitaine de la ville Tokyo.

  1. Binpaku Shiraiwa, l’ancien administrateur de l’Association des Apicultures Japonais s’est occupé de l’acuponcture avec’ abeilles après 1915 et a soutenu la création d’une école d’acuponcture par abeilles dans le cadre du Ministère de la Santé et de la Prospérité en 1939. Pendant ce temps, le journal “Nihon Yoho Shimbun”, est devenu le centre des activités de promotion de l’acuponcture en organisant des séminaires d’acuponcture dans le bâtiment des organisations apicoles, en mettant ainsi les bases de cette discipline qui c’est étendue jusqu’à présent. Au début la méthode spartane avec des piqûres directes a été évitée par le public.  L’acuponcture avec abeilles était patronnée, seulement par un secteur des apiculteurs.

En octobre 1979, l’Association japonaise d’études pour l’acuponcture avec abeilles dont le promoteur était “Nihon Yoho Shimbun” a été créé.  Il est inutile de mentionner que cela s’est réalisé avec l’aide substantiel des prédécesseurs, comme N. Ohta, Hashimoto, Yamada et Yonekura qui ont fait 20-30 ans de recherches apicoles.  On a pu faire de grands progrès car ces prédécesseurs ont dévoilé les secrets de leur art.

Le changement de la méthode des piqûres directes qui donne l’impression que les piqûres des abeilles sont douloureuses, avec la méthode des piqûres sans douleur a contribué à l’utilisation à grande-échelle de l’acuponcture avec abeilles.

Le but de la thérapie de l’acuponcture japonaise avec abeilles est d’établir les bases de l’acuponcture avec abeilles, qui occupe déjà une position primordiale parmi les remèdes domestiques et d’obtenir des connaissances sur la manière avec laquelle l’acuponcture et la moxibustion ont été acceptées par le public.  Nous devons à présent réunir les données expérimentales des membres, orienter notre attention vers les chercheurs de prestige et essayer de convaincre la population.

Les séminaires organisés par l’Association ont lieu deux fois par an. En plus, les associations d’apiculteurs préfectorales et les filiales organisent leurs séminaires pour répandre l’acuponcture avec abeilles.  On attend de ces séminaires non seulement une augmentation des ventes de miel, mais une promotion aussi des produits apicoles comme la gelée royale, le pollen et le miel, comme nourriture saine et efficace.

Comme au Japon il n’y a pas de possibilités d’obtenir des certificats pour utiliser la thérapie de l’acuponcture avec abeilles, les nouveaux venus ne peuvent pas la pratiquer.  L’acuponcture avec abeilles sans approbation est évidemment illégale donc l’association recommande de ne pas le pratiquer.

L’association accorde des permissions de pratiquer l’acuponcture aux personnes qui passent un examen devant des apiculteurs connus et appréciés.  Ce système atteste les mérites techniques d’une personne qui pratique l’acuponcture avec abeilles en qualité de “consultant”, une pratique semblable à la qualification des instructeurs qui certifie la qualité de la cérémonie du thé ou de la caligraphie.  Le président de la Société Japonaise d’Acuponcture et un membre de la Chambre Supérieure, Kentaro Takagi, ont soutenu récemment la valeur de l’acuponcture avec abeilles.  Quand dans sa jeunesse, il y a 30 ans, M. Takagi a commencé l’étude et a soutenu l’acuponcture, il a été calomnié parce qu’on disait qu’il n’était pas normal pour un médecin d’être superstitieux.  A présent, remarque-t-il, il y a une différence énorme entre le niveau de l’acuponcture d’aujourd’hui, avec une université spécialisée, et celui d’autrefois.

J’ai entendu que dans d’autres pays également, l’acuponcture avec abeilles est ridiculisée et considérée comme un traitement imaginaire.  Pourtant, elle sera reconnue, comme on a reconnu l’acuponcture et la moxibustion.  Je croix que le XXIé-e siècle sera une ère brillante pour l’acuponcture avec abeilles.

La raison pour laquelle l’acuponcture avec abeilles a gagné une position de premier ordre parmi les remèdes domestiques est la révélation de leurs effets surprenants.  Par exemple, si nous avons une enflure dans la bouche, elle nous ennuyera quelques jours, deviendra purulente, et nécessitera un traitement avec des antibiotiques.  Cette plaie sera guérie avec deux ou trois piqûres directes ou aiguillons d’abeilles.  Les gencives enflées et douloureuses cesseront de faire mal 30 minutes après la piqûre et l’enfflure se réduira en quelques heures.

Bien que la médecine ait progressé, une meilleure alternative est inimaginable.  Le traitement du rhumatisme est difficil et le moyen le plus efficace d’anihiler la douleur est d’employer un analgésique antiflogistique.  En accord avec les recherches du Prof.  Rangel de l’Université de Prague, les bactéries qui provoquent le rhumatisme cessent leur activité quand elles sont introduites dans une solution de venin d’abeilles diluée mille fois.  Il y a beaucoup de cas de guérison radicale de ces maladies réfractaires au traitement.

Parce que la majorité des maladies qui attaquent l’homme sont provoquées par les bactéries et virus, l’histoire de l’humanité peut être considérée comme une lutte contre les bactéries.  Dans le cas de la destruction des bactéries par venin d’abeilles, les bacteriés qui provoquent l’affreux cancer ne font pas exception.  Les bactéries cancérigènes sont détruites immédiatement après la pénétration du venin d’abeilles.  J’attends l’introduction d’une nouvelle thérapie par laquelle le cancer caché dans le corps humain sera attaqué par un injecteur qui puisse y arriver.  Les gens souffrant de verrues ou de calvities seront surpris du pouvoir de guérison du venin d’abeilles.

La thérapie de l’acuponcture avec abeilles a la qualité de désinfecter ; il faut accorder de l’attention à son effet purificateur sur le sang.  Tout le monde sait qu’une portion bleu à la suite d’une contusion revient à la couleur normale après des piqûres d’abeilles.  Quelle autre méthode peut assurer un rétablissement immédiat ?

Les practiciens renommés montrent que dans le cas des pacients faisant de l’hypertension qui ont diminué leur tension par acuponcture, une rechute apparaît rarement.  On connaît des cas récents de gens qui guérissent de trombose cérébrale ou d’autres maladies.  J’espère que l’importance de l’acuponcture avec abeilles sera reconnue.  Dans la thérapie de l’acuponcture avec abeilles on suit la voie d’entrée de la maladie dans les points méridiens de la Médecine Orientale et le traitement est concentré sur certains points d’interférence.  Dans le cas de la névrite herpétique, une maladie persistante qui se manifeste par zona-zoster et douleurs, 3 ou 4 aiguillons appliqués dans le foyer pathogène sont suffisants pour la guérison; si on ne peut pas localiser les points méridiens, on peut appliquer les aiguillons sur le point douloureux, qui lui démange ou qui est engourdi.  Une fois, quand je pêchais dans un ruisseau, l’articulation de mon genou droit est devenue douloureuse et rigide.  J’ai capturé trois abeilles qui étaient venues butiner dans un champs de blé et j’ai appliqué leurs aiguillons dans la région douloureuse.  Je me suit remis en quelques minutes.  Plus tard, quand j’ai affirmé dans une conférence que la où il y a des fleurs, il y a des abeilles, j’ai reçu des plaintes de la part des apiculteurs qui m’ont reproché que ces affirmations faisaient réduire les ventes d’abeilles.  J’ai entendu aussi beaucoup d’apiculteurs qui prévoient que les médecins auraient moins de pacients si ceux-ci pouvaient se guérir plus vite et avec moins de rechutes par l’acuponcture avec abeilles.

Notre but est de faire des recherches sincères et de répandre la santé en travaillant ensemble avec le monde entier.  L’Association japonaise d’études sur la thérapie de l’acuponcture avec abeilles est constituée de médecins, spécialistes en thérapie par acuponcture et moxibustion, spécialistes en thérapie callisthénique, apiculteurs etc.  La sixième année de sa création, les médecins spécialisés, ayant à la tête M. Yoshimoto de Kodaira, Tokyo, ont commencé les recherches; la présentation des cas cliniques constituera un grand pas en avant.

Selon les journaux de Chine, un hôpital spécialisé en acuponcture

avec     abeilles, ouvert ce printemps, a enregistré un taux, de guérison de

70 % pour les névralgies et les rhumatismes.

Récemment, on a posé le problème des practiciens sans licence.

Le Département de la Santé et de la Prospérité affirme que la pratique de l’acuponcture est permise seulement aux médecins et aux personnes qui possèdent une approbation.

C’est le point de vue du Ministère qui ne possède pas de données et ne comprend pas la signification de l’acuponcture avec abeilles. Nous demandons votre support généreux pour des recherches sur l’acuponcture avec abeilles pendant que nous continous de trouver de nouvelles possibilités par l’instruction correcte de méthodes à remèdes domestiques et le respect des lois.

 

[iv] Melanotropin (MSH) receptor activity in the M2R mouse melanoma cell line is tightly controlled by calcium by an unknown mechanism. The possibility that calcium regulation is mediated by calmodulin or a calmodulin-related calcium binding protein has been addressed in this report by studying the effects of two known calmodulin antagonists, fluphenazine and melittin, on MSH receptor function. Stimulation of adenylate cyclase (AC) in M2R plasma membranes by beta MSH was strongly inhibited by both antagonists. The concentrations of fluphenazine and melittin yielding half-maximal inhibition (IC50) of AC were 16

microM and 2.4 microM, respectively. Both fluphenazine and melittin also

inhibit prostaglandin E1-, GTP gamma S, and forskolin-stimulated AC activity, as well as that of unstimulated enzyme, although inhibition is shown to occur at significantly higher concentrations of antagonist. We have shown that the calcium-dependent rate-limiting step in MSH stimulation of adenylate cyclase, that of hormone binding, is strongly inhibited by these antagonists at concentrations identical to, if not lower than, those required for the inhibition of AC activity (fluphenazine-IC50, 14 microM; melittin-IC50, 0.7 microM). The actions of these antagonists, furthermore, appear to be calcium insensitive, as melittin affects the stability of both the high affinity (calcium containing) and low affinity (calcium depleted) receptor-MSH complexes. The sensitivity of the MSH receptor to inhibition by calmodulin antagonists resembles that described for purified calmodulin-sensitive enzyme systems, which suggests a possible role for calmodulin in MSH receptor function. Among peptide hormone receptors, this effect by calmodulin antagonists appears to be unique for the MSH receptor.

 

PMID: 3665846, UI: 88029249

 

[v] Higuchi, M. (1992)  –  Damage to mitochondrial respiration chain is related to phospholipase A2 activation caused by tumor necrosis factor,
            in J Immunother Jul;12(1),  pp.41-49.

 

Division of Chemical Toxicology and Immunochemistry, Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

 

[vi] Tumor necrosis factor (TNF) has been shown to be cytotoxic to tumor cell lines in vitro, but the mechanism by which TNF exerts its cell growth-regulatory effects is not known. In this report, we used various inhibitors to investigate the sequence of events that lead to cytotoxic effects of TNF on L.P3 cells, a highly sensitive, murine fibroblast cell line. Our results indicate that mitochondrial respiration chains are damaged by a hydroxyl radical at an early stage of the cell lysis after TNF treatment. This event is followed by the activation of phospholipase A2, and finally leads to cell lysis.

[vii] Saini, S. S. et al address: Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston 77555-1070, USA. sssaini@utmb.edu

[viii] Saini, S. S.;  Chopra, A. K.;  Peterson, J. W. (1999) (USA)  – Melittin activates endogenous phospholipase D during cytolysis of human monocytic leukemia cells,
            in Toxicon 1999 Nov; 37(11),  pp.1605-19.

Human monocytic leukemia cells (U937) were challenged with synthetic melittin, and arachidonic acid (AA)/acylated lipids from both cells (pellet) and media (supernatant) were analyzed by thin layer chromatography (TLC). From these data, melittin-mediated activation/inhibition of major phospholipases in U937 cells was related to pore formation, permeabilization and cytolysis as determined by light microscopy. Also, the effect of melittin on acylhydrolase activity in the cell-free sonicated lysates of U937 cells was examined. Here we report that synthetic melittin (1 microM) caused cytolysis of U937 cells within 10-15 min. Cellular hypertrophy (5 min) and aggregation (1 min) preceded cytolysis. TLC analysis of these lipids showed that total levels (cellular + medium) of diacylglycerol (DAG), phosphatidylethanolamine (PE) and phosphatidylcholine (PC) decreased, while that of arachidonic acid (AA) increased continuously (5-30 min). However, levels of phosphatidylethanol (PEt) phosphatidic acid (PA) and phosphatidylserine (PS) were increased transiently at 5-10 min being maximal at 5 min. Taken together, the combined levels of PEt and PA (an end product of phopholipase D, PLD) were about 42-fold higher than the level of AA at 5-10 min. Enhancement of AA levels appeared to result from in vitro reactions of various acylhydrolases and their phospholipid substrates (free/membrane bound) liberated into the medium during pore formation/cell lysis. Incubation of sonicated cell lysates also enhanced release of AA, which decreased upon addition of melittin, indicating that melittin inhibited these acylhydrolases. A consistent decrease in the level of DAG showed that phospholipase C was unaffected. Hence, transient activation of PLD bymelittin at the point of initiation of cytolysis, suggested a role for PLD in melittin-mediated membrane disruption/cytolysis by an uncharacterized signal transduction mechanism.
PMID: 10482394, UI: 99410120

 

[ix] Address: Department of Microbiology and Immunology, University of Tennessee, Memphis 38163.

 

[x] Sharma, S. V. (1992) (USA)  –  Melittin resistance: a counterselection for ras transformation,
            in Oncogene, Feb;7(2),  pp.193-201.

 

                The prevalence of activated ras oncogenes in human primary tumors suggests a central role for this oncogene in human cancer.
                Despite its ubiquitous distribution, the biochemical role of the oncogene remains unclear, and hence attempts to control its activity have been frustrated.
                This study demonstrates the ability of melittin, a 26 amino acid, amphipathic peptide from bee venom, to specifically select against cells in culture that express high levels of the ras oncogene.
                Acquisition of resistance to increasing concentrations of melittin is accompanied by corresponding decreases in the levels of expression of the ras oncoprotein and the number of copies of the ras gene. This results in a concomitant reversion of transformed cells to a normal morphology in a strict dose-dependent manner.
                Melittin is a known activator of cellular phospholipase A2 (PLA2), and these results suggest an interrelationship between ras and PLA2.
                In addition these studies indicate that melittin preferentially hyperactivates PLA2 in ras oncogene-transformed cells, resulting in their selective destruction.

 

[xi] Bavarian Nordic Research Institute, Munich, Germany.

 

[xii] Winder D, Gunzburg WH, Erfle V, Salmons B [xii] (1998) (Germany)  – Expression of antimicrobial peptides has an antitumour effect in human cells,
            in Biochem Biophys Res Commun Jan 26;242(3),  pp.608-612.

 

The antimicrobial peptides cecropin and melittin are known to exhibit

antitumour activity in tumour derived cell lines. To achieve a similar effect in vivo these peptides would have to be given repeatedly to maintain therapeutic levels, which may be pharmacologically unfavourable. The expression of the genes encoding such antimicrobial peptides in the desired cell type may circumvent

these problems. Expression constructs carrying cecropin or melittin have

been introduced into a human bladder carcinoma derived cell line and the resultant cell clones analysed for tumorigenicity in nude mice.

Expression of cecropin resulted in either a complete loss of

tumorigenicity in some clones or reduced tumorigenicity, as measured by latency of tumour formation.

These results suggest that vector mediated delivery of this gene to tumour cells may prove useful for cancer gene therapy.

 

 

References on the use of Honey against cancer:

 

  • *** Science News 144 (1993) –  Sweet route to heading off colon cancer,  207.

 

  • *** American Health Foundation (1994) (USA) –  Honey helps against colon cancer,
         in First Magazine;
         in Bee Culture;
         in Bee sCene, volume 10, # 3, July,  15 (***-abstract).

 

  • Cavanagh, D.; Beazley, J.;  Ostapowicz, F. (1970)    Radical Operation for Carcinoma of the Vulva. A New Approach to Wound Healing,
         in Obstet. Gynaecol. Br. Cmwlth. 77,  pp.1037-1040.

 

  • Fulker, M. J.; Jackson, D.;  Leonard, D. R.;  McKay, K.;  John, C. [i] (1998) (UK)  – Dose due to man-made radionuclides in terrestrial wild foods near Sellafield,
         in J Radiol Prot Mar;18(1),  3-13. [ii]

 

  • Gribel’, N. V.; Pashinskii, V. G. (1990) (Russia)  –  The antitumor properties of honey (original article in Russian),
         in Vopr Onkol 1990;36(6),  704-709 (***-abstract). [iii]

 

  • Jones, Richard (1997) (UK) –  Science Round-up. Honey and healing,
         in Bee World, vol. 78, No. 3 (***). [iv]

 

  • Keast-Butler, J. (1980) –  Honey for necrotic malignant breast ulcers,
         in Lancet 1980; ii(October 11),  809.

 

  • Khaled Mohey Eldin Elawdan & Ezzat A.El-Drieny (2000) (Egypt) –  Ultra-Structural Changes of Normal Rat Brain with Local Application of Honey,
         in the 4th Congress of European Association of Neuro-Oncology,
    Copenhagen, Denmark, June 2000 (Neuro-Oncology Journal, Volume 2, Supplement 1, July 2000, page:S45). [v]

 

  • Khaled M.E.Elawdan, Abo Alazm Hospital, Mehalla El-Kobra, Gharbia (2000) (Egypt) –  A New Trend in Management of Malignant Gliomas: Case Report,
         in the 4-th Congress of European Association of Neuro-Oncology,
    Copenhagen, Denmark, June 2000 (Neuro-Oncology Journal, Volume 2, Supplement 1, July 2000, page: S51). [vi]

 

 

  • Khaled M.E.Elawdan and Ezzat A.El-Drieny; Abo Alazm Hospital, Gharbia (2000) (Egypt) –  In vitro Study of the Effect of Various Types of Honey and Bee Pollen upon Different Malignant Cell Lines,
         in the 4-th Congress of European Association of Neuro-Oncology,
    Copenhagen, Denmark, June 2000 (Neuro-Oncology Journal, Volume 2, Supplement 1, July 2000, page: S52). [vii]

 

 

  • Mickevicius,Juozas, Milasiene,Vida,  Breivis,P.,  Kersiene,R.,  Narbutiene,G.,  Kadziauskiene,Kamelija,  Norkiene,V. (1997) (Lithuania)  –  Use of honey and pollen in the chemotherapy of cancer patients,
         in the XXX-Th. Apimondia Congress, Antwerp, Belgium (***). [viii]

 

  • Molan, P. C.; Allen, K. L. (1996) (New Zealand) –  The effect of gammairradiation on the antibacterial activity of honey,
         in Journal of Pharmacy and Pharmacology 48,  1206-1209.

 

  • Mossel, D. A. A. (1980) –  Honey for Necrotic Breast Ulcers,
         in Lancet ii,  1091.

 

  • Postmes, T.; van den Bogaard, A. E.;  Hazen, M. (1995)  –  The sterilisation of honey with cobalt 60 gamma radiation: a study of honey spiked with Clostridium botulinum and Bacillus subtilis,
         in Experentia (Basel) 51,  986-989.

 

[i] Westlakes Scientific Consulting Limited, Westlakes Science and Technology Park, Cumbria, UK.

[ii] Radiological dose implications for consumers of wild foods around Sellafield have been assessed. Habits were surveyed from 72 households, mostly within a few kilometres of Sellafield. A few people were included who lived further away but collect wild foods close to Sellafield. Dose estimates were based on measured gamma emitters, as well as 239Pu, 241Am, 14C and 129I in selected samples. In all cases, doses were dominated by 137Cs. One infant was identified who consumed wild food, giving an estimated effective dose of 0.3 microSv a(-1). In the age group 2 to 10 years a mean dose of 0.51 microSv a(-1), and a maximum of 2.8 microSv a(-1), were estimated. Intakes by adults were higher and resulted in more radiologically significant doses. The extreme individual received a dose of 32 microSv a(-1) largely due to consumption of honey that included contributions from the Chernobyl accident, and hedgerow fruits. This is comparable to doses to the critical group for consumption of conventional agricultural produce close to the Sellafield site. The 97.5th percentile dose, for all age groups of consumers taken together, was 16.6 microSv a(-1), or 6.2 microSv a(-1) if the contributions from Chernobyl are excluded. Considering the contributions from different foods to the whole group of 181 wild food consumers, the rank order is honey, blackberries and venison.

 

[iii] The experimental evaluation of antitumor properties of honey was carried out using five strains of rat and murine tumors. Honey revealed moderate antitumor and pronounced antimetastatic effects. Honey potentiated the antitumor activity of 5-fluorouracil and cyclophosphamide.

 

[iv] Science Round-up. Honey and healing

 

As anyone who has seen the film – Jurassic Park knows, fossils bear witness to the existence of insects on earth in the Carboniferous period of the Palaeozoic era before the existence of humans.  Bees, in relatively unchanged form, have been around for over 50 million years. It is not surprising therefore that their involvement with humans must pre-date history.  Cave paintings in Europe dating from 10 000 years BC depict man hunting honey which seems to have been recognized from the beginning as a precious product and cure for ills1.  The oldest written record is a Sumarian tablet, possibly dated 3000 BC having a prescription using honey to treat a skin infection or ulcer.  One of the earliest references in literature that contains solid statements about the curative properties of honey is found in the Koran where it says that God inspired bees to eat from all fruits to produce liquids of different colours in which there are cures for man2.

 

In Ancient Egypt, the honey bee formed part of the Pharaoh’s cartouche, used to denote the king of Lower Egypt.  Honey bees were kept in hives very similar to the mud hives still used in Egypt today.  Papyrus writings from that time were acquired in the mid- 19th century by Dr. Edwin Smith, an American scholar.  Over 70 years later James Breasted succeeded in translating the document.  Known as the Smith papyrus it gives a remarkable picture of medicine and surgery over 4000 years ago – including 48 case studies.  One of these describes a gaping wound of the eyebrow, penetrating to the bone.  The treatment was as follows:

 

‘Now after thou has stitched it, thou shouldst bind fresh meat upon it the first day. If thou findst that the stitching of the wound is loose, draw it together with two strips [sutures] and thou should treat it with grease and honey every day until he recovers.’3

 

The same papyrus gives many other prescriptions, for example wounds and ulcers were treated with linen soaked in frankincense and honey, while honey mixed with aniseed, sycamore and frankincense could be used as a gargle for treating mouth ulcers and sores.  A most improbable mixture is that of malachite (copper carbonate) and honey for warding off eye conditions.  Yet similar prescriptions occur a thousand years later in ancient Greece and 1 500 years after that in medieval England.

 

The first book on honey in the English language was written by John Hill and printed in 17594. It has the very unmarketable title: The virtues of honey in preventing many of the worse disorders; and in the certain cure of several others, particularly the gravel, asthma, coughs, hoarseness, and a tough morning phlegm.  We have this book in the IBRA library and I think it is very apt to quote the first paragraph:

 

‘The slight regard at this time paid to the medicinal virtues of Honey, is an instance of neglect men shew to common objects, whatever their value: acting in contempt, as it were, of the immediate hand of providence, which has in general made those things most frequent, which have the greatest uses; and for that reason, we seek from the remotest part of the world, medicines of harsh and violent operation for our relief in several disorders, under which we should never suffer, if we would use what the Bee collects for us at our doors.’

 

In the library we also have a paper which concludes that honey is grossly under-utilized in conventional medicine.  That paper was published in 1989 – 230 years later in the Journal of the Royal Society of Medicine and originated from the medical school of Hammersmith Hospital in the UK5.

 

There is not one of us who has not heard of granny’s recipe of honey and lemon for a cough; although as we grew up we probably preferred the honey and whisky variant. It has become part of folk medicine and also a huge commercial undertaking.

 

Many hundreds of tonnes of honey are used each year in commercially manufactured pharmaceutical products. It is also used as a base for ointments.  This is quite prevalent in Russia where honey itself is used to treat burns. It has been used in Britain as a surgical dressing for open wounds, burns and septic infections being non-adhesive it has proved to be more comfortable than other dressings.

 

The folklore and history are fine but where is the hard evidence?

 

The therapeutic qualities of honey have been rediscovered and its antibacterial properties recognized if not fully understood.  A large amount of research work has been done but because the work is so widespread both in time and geography and then published in many different journals and in many languages it is difficult to assess all the findings.

 

It was established in 1919 that honey has antibacterial properties and these have been attributed in part to the osmotic effect that it can create.  The high concentration of sugars in honey give it a hydroscopic quality.  Through the process of osmosis it dehydrates and so kills bacteria.  There are additional factors and it is difficult to ascertain the extent to which these factors work either independently or in conjunction within the healing process.  For example, older literature refers to the presence of a substance – inhibine – this has been found to be hydrogen peroxide3.  Hydrogen peroxide is produced in a reaction between glucose and oxygen.  Furthermore, the low pH (3.7) of commercially produced honey creates an instantly unfavourable environment for bacterial growth which cannot be achieved by granulated sugar6.

 

The viscosity of honey makes it a good barrier compound; its water solubility allows easy removal, while its mild noncorrosive properties prevent any additional harm to either damaged or healthy tissue1.

 

There are many records of the use of honey and descriptions of its biological effects. But use sometimes implies effectiveness and can be given extra weight by frequent repetition.  However, actual effectiveness is far harder to define.

 

In 1991 Subrahmanyam8 carried out a conventional method of burn treatment with topical application of honey.  Patients (104) were divided into two groups. In both cases the burns were cleaned with saline solution.  The one group then had pure, undiluted unprocessed honey applied and rebandaged daily.  The second group had gauze soaked in 5% silver sulfadiazine applied daily.  Within 7 days 91% of the infected wounds treated with honey were rendered sterile compared to less than 7% in the other group.  Of the wounds treated with honey, 87% had healed within 15 days compared with 10% in the control group.

 

It is suggested that the effectiveness of the treatment of burns is because:

 

  • Honey prevents infection because of antibacterial properties
  • Honey provides a viscous barrier to fluid loss and wound invasion by bacteria thus preventing infection
  • Honey contains enzymes which may aid healing and promote tissue formation
  • Honey absorbs pus thereby cleaning the wound
  • Honey reduces pain, irritation and eliminates offensive smells

Efem9 showed that various types of wounds and skin ulcers that had not responded to conventional treatment responded favorably to honey.  The wounds treated included burns, gangrene, varicose ulcers, diabetic ulcers and bed sores.  Cleaned wounds had honey and clean bandages applied daily.  The dressing proving to be extremely comfortable as, surprisingly it did not stick to the wound. Within 7 days wounds were free from infection, dead tissue was quickly replaced with healthy granulation tissue.  Thus it would appear that the antibacterial properties of honey work on skin ulcers in the same way as they work on burns.  Similar results have been recorded by Kaegi10 and Rieder11 in Switzerland, both of whom treated a variety of ulcers, pressure sores, abscesses and fistulas with honey. It is interesting that honeydew honey was used in treatments because its low pollen content reduces the risk of pollen-allergic reactions.

 

Also in Switzerland honey has been used to treat sickness arising from radiation treatment.  While German researchers found that the high fructose levels stimulate the metabolism of alcohol and so use it to help sober up drunken patients.

 

Dilute honey administered orally or intravenously has been shown to be effective in treating gastro-enteritis12.  While New Zealand manuka honey is said to successfully inhibit Helicobacter pylori, the causative agent of stomach ulcers13.

 

Skin grafts have been successfully stored for up to twelve weeks in sterile, undiluted, unprocessed honey14.

 

It can be seen that honey has a long track record of medical use.  Both when administered orally or used as a dressing.

 

A word of caution

 

In the past the only source of food for bees was nectar from flowers; nowadays, bees are kept in modern movable-frame hives, and may produce totally or partially non-floral honey, if they have been fed on sugar syrup.  The honey extracted from such colonies does not differ much in colour or major components from floral honey, but may have inferior curative properties7, which places all honeys under suspicion.

 

Furthermore, honeys vary according to their plant origins and the conditions under which they are produced.  Physical and chemical characteristics may be changed by processing and storing, while the biological properties of honey are subject to all types of variation associated with living organisms.

 

Honey from other bees

 

So far I have not mentioned the differences in honey produced by bees other than Apis mellifera, the European honey bee.  For example, the honey from the Asian hive bee, Apis cerana, in China was used for centuries to prevent smallpox scarring.  Honey from stingless bees of central America the Meliponinae – is a different substance but it too has even greater claims to medicinal properties, e.g. records show it has been used in the treatment of eye diseases since the Mayan civilization.

 

Conclusions

 

One of the problems with honey and healing is disentangling the folklore from serious research and then to seek out the reports arising from that research.  For this very short and very simple overview I have had to dip into medical journals from the UK and elsewhere, text books on apiculture published in the UK, the USA, New Zealand, Australia and Thailand, as well as bee journals from more than half-a-dozen countries and in several languages.

 

It is, therefore, unique in this subject area to have access to so many sources of information under one roof.  IBRA has abstracts of almost every article published on the topic and in most cases the full paper is also available.  We can produce bibliographies and conduct subject searches.

 

If I have in ignorance wandered too far into a medical field which is not my own or failed to cover in depth an issue of particular interest – forgive me. I am but the curator of a national, no international, treasury of Scientific research that you are welcome to use and visit. In that way you will support us in our task of maintaining and developing our resources for future reference.

 

Further reading

 

A 76-page reprint of the 2-part article by Peter Molan ‘The antibacterial activity of honey’, published in Bee World (1992), is available from the IBRA BookShop priced £2.70 (includes p & p to a UK address; add 10% (surface) or 15% (airmail) for delivery elsewhere.

 

A selected annotated bibliography on ‘Honey in medicine’ is available from the Librarian, IBRA, 18 North Road, Cardiff, UK. Price £2.50 (including p & p to a UK address, or £3 elsewhere).

 

References

 

  1. CRANE, E (1979) Honey: a comprehensive survey. Heinemann; London,, UK.
  2. CRANE, E (1983) The archaeology of beekeeping. Duckworth; London, UK.
  3. MANJO, G (1 975) The healing hand. Harvard University Press; USA.
  4. HILL, J (1759) The virtues of honey. Davis; London, UK.
  5. ZUMLA, A; LULAT. A (1989) Honey – a remedy rediscovered. Journal of the Royal Society of Medicine 82: 384-385.    
  6. BOSE, B (1983) Honey or sugar in the treatment of infected wounds.  The Lancet April: 963.
  7. BANBY, M A et al. (1988) Healing effect of floral honey from sugar-fed bee, on surgical wounds (animal model). Proceedings of the 4th International conference on apiculture in tropical climates, Cairo, 1988. IBRA; Cardiff, UK; pp 46-49.
  8. SUBRAHMANYAM, S (1991) Topical application of honey in the treatment of burns. British Journal of Surgery 78: 497-498.
  9. EFEM. S E E (1988) Clinical observations of the wound healing properties of honey, British Journal of Surgery 75: 679-681
  10. KAEGI, C (1995) Honey for healing. Schweitzerische, Bienen-zeitung 118: 590, 592.
  11. REIDER, K (1995) Wound and treatment with honey. Schweitzerische Bienen-zeitung 118: 579.
  12. HAFFEJEE, L E; MOOSA, A (1985) Honey in the treatment of infectious gastroenteritis. British Medical Journal 290: 1866-1867.

      13, SOMAL, N A et al (1994) Susceptibility of Helicobacter pylori to antiobiotic activity of manuka  honey, Journal of the Royal Society of Medicine 87: 497-498.

  1. SUBRAHMANYAM, S (1993) Storage of skin grafts in honey. Lancet 341: 63-64

RICHARD JONES

Director, IBRA

 

         International Bee Research Association

         18 North Road, Cardiff, CFI 3DY, UK

         Tele: +44 (0) 1222 372409

         Fax: +44 (0) 1222 665522

         E.mail: ibra@cardiff.ac.uk

         Web: http://www.cf.ac.uk/ibra/  

 

[v] Aim of Work: We have found an inhibitory effect for clover type of honey upon GS-9L glioma cell line (abstract 315), so, our aim was to identify the possible ultra-structural changes upon normal brain with local application of honey.
Material & Methods: Clover type of honey, 12 rats with average weight of 200 grams and dextrose 50% as a control. When we started with a volume of 75-100 micron to be injected in the right cerebral hemisphere, it was noticed that in mainly the dextrose group signs of meningism, irritability, repeated biting of its tail, scratching of its head and even death in some have been occurred. With revision of our trial using only25- 50 micron of honey compared to the same volume of dextrose 50% to be injected in the right cerebral hemisphere, these signs apparently diminished.
The rats were sacrificed after 1,2,3,7,15 & 30 days.
Intra-cerebral and intra-ventricular heamatoma was found in 4 rats of dextrose group and not found in honey group.
Semithin sections from each group have been done:
In the dextrose group: areas of necrosis, hge and severe congestion.
In honey group: mild to moderate congestion, no hge, thickened wall of blood vessels and in one case moderate area of necrosis was found.
Selected samples from each group have been taken for electron microscope study:
E/M of dextrose group: Rupture & swollen of mitochondria, cytoplasm vacuolation in glial cells, congested blood capillaries, hge, necrosis, swollen of axons of perivascular plexus, destructive myelin and dextrose crystals in & outside neuroglial cells.
E/M of honey group: Changes are restricted to the first 2 or 3 days. Mild congestion & myelin degeneration in one case.
Glial cells proliferation and otherwise normal

 

[vi] Purpose: To find a safe and effective treatment for gliomas. We have found an inhibitory effect for honey and its bee pollen upon GS-9L cell line, and the ultra-structural changes with local application of honey upon normal rat brain compared to dextrose 50% were also identified (abstracts 275 and 316).
Materials & Methods: Clover type of honey and its bee pollen; umbrella of dexamethasone, phenytoin, dehydrating measures, ranitidine and may be antibiotic.
Through a burr hole, biopsy was taken and 1-3 ml of honey was injected intra or/and near tumour site and this was repeated 8 times during a course of 6-8 weeks.
Adverse reaction: Meningism, headache, fever, disturbed level of consciousness and hypertension. Follow-up C.T and / or MRI of brain have been done during and after our course.
Result: Gradual reduction in mass size started to appear just 2 weeks from beginning of the course of treatment and after more than 5 years follow up, no recurrence.
I assumed tumour inhibitory factors (T.I.Fs) to be found in honey protein and pollen.
Honey as well has acidic pH improper to glioma cells growth.
Actually, I introduce honey and its bee pollen to be as a penicillin revolution in the management of malignant brain tumour to be applied intracranially and/or intrathecally through possible 2 mechanisms: tumour inhibitory factors, apoptotic factors and pH change.

 

[vii] Introduction: The prognosis of many types of malignancy still poor or very poor in spite of the great advances in management. One of those categories with very poor prognosis is malignant glioma. So, any trend aims to have any solution for these challenges must be evaluated.

Materials and Methods: 8 types of malignant cell lines (glioma GS-9L, hepatoma HTC, sarcoma XC, fibrosarcoma RT1, breast carcinoma MCF7, leukemia K-562, leukemia HL-60 and lung carcinoma COR-L23); 8 types of honey, bee pollen, floral pollen and dextrose 50%. After cell growth, 50 microns of every type of honey was added to the culture media of each cell line compared to the same volume of dextrose 50% in one group. In another group, 20 milligrams of every type of bee pollen was introduced to each cell line compared to the same weight and type of floral pollen.

Number of cells was counted in each case.

Result: Number of cells was apparently diminished in certain types of cell lines with specific type of honey.
The same result was obtained with the same type of bee pollen and not floral pollen.
Samples from each type of cell lines were taken to identify the possible ultra-structural changes and possible mechanisms through electron microscope study.

Conclusion: Each type of honey has an optimum inhibitory effect upon certain types of cell lines but not the others. Each type of bee pollen but not floral has the same inhibitory effect and specification.

Biologically active materials have been postulated to be found in bee pollen and not in floral pollen: worker bee related factors let us call W.Factors and pollen related factors let us call P.Factors.

Tumour Inhibitory Factors (T.I.Fs) have been assumed to bee found in honey protein and bee pollen.

Extension trial with larger number of malignant cell lines and much more various types of honey and bee pollen must be done.

 

 

[viii] THE USE OF HONEY AND POLLEN IN THE CHEMOTHERAPY OF CANCER  PATIENTS

 

  1. MICKEVICIUS, V. MILASIENE, P. BREIVIS,                R. KERSIENE, G NARBUTIENE,  K. KADZIAUSKIENE, V. NORKIENE

                                (LITHUANIA)

 

Our investigation indicates positive changes caused by honey and pollen in the immune and antioxidative systems, when applying surgical treatment to gastric and colon-rectal cancer patients.

             The aim of this work is to evaluate the impact of honey and pollen on the immune system and on the antioxidative and blood-forming systems in gastric and colon-rectal cancer patients, when they are administered chemopreparations.

76 patients with gastric and colon-rectal cancer have been investigated, as they were administered chemopreparations. 41 of them used honey and pollen simultaneously with the specific treatment and 35 used chemopreparations, but no bee products.

The Lithuanian Nutrition Center performed hygienic, chemical composition and biological analyses on honey and pollen.

The hematological indicators (leucocytes, lymphocytes, neutrophiles, monocytes, thrombocytes); the indicators of cell and humoral immunity (T-lymphocytes (CD3+), T-helper cells (CD4+), T-cytotoxic cells (CD8+), B-lymphocytes (CD20+), natural killers (CD16+): the blast level and the activity of neutrophiles (by the NTB test), as well as the G, A, M class immunoglobulin concentration in the peripheral blood circulation and the indices that reflect the activity of the antioxidant system (DK and MDA value and SOD -superoxydismutasis-  activity) were determined in the respective patients.

The analysis of the data obtained showed that the patients who did not use bee products had a lower level of CD3+, CD4+, CD8+, CD20+ and CD16+ cells but the MDA concentration in their peripheral blood circulation increased.  Other statistical indicators did not change.

In the patients using bee products, we noticed an increase in the number of CD3+ cells during the treatment, while the number of CD4+, CD8+, CD20+ and CD16+ cells did not change statistically and the MDA and DK value decreased in the peripheral blood circulation.
          In this group, the number of thrombocytes also decreased during the treatment.

The results obtained indicate that bee products cause positive changes in some indicators of the immune and antioxidative systems in patients with gastric and colon-rectal cancer in the third and the fourth stage, when they are subject to chemotherapy.

 

                                                                                                                                                  p.122-123

 

References on the use of Bee pollen against cancer:

 

·        *** Thorsons Eds. (1979, 1989)  –  The Healing Power of Pollen with Propolis and Royal Jelly.
    
Wellingborough, Northhampshire: Thorsons Publ. Group.         ISBN 0-7225-1878-1.  112 pp.
(***).

 

 

·        Bevzo V. V; Grygor’eva N. P. (Ukraine) (1997)  –  Effect of bee pollen extract on glutathione system activity in mice liver under X-ray irradiation [Article in Ukrainian],
     in Ukr Biokhim Zh  Jul-Aug;69(4):115-7. [i]

 

 

·     Dudov, I. A.; Starodub, N. F. (Ukraine) (1994)  –  Antioxidant system of rat erythrocytes under conditions of prolonged intake of honeybee flower pollen load [Article in Russian],
     in Ukr Biokhim Zh Nov-Dec; 66(6),  pp.94-96. [ii]

 

 

·        Hakim, H. (1987) (France)  –  Le pollen: Aliment -Medicament. (les radicaux libres; la beta-endorphine).
    
UNAF.

 

 

·     Hernuss,P.,  Müler- Tyl,E.,  Salzer,H., Sinzinger,H.,  Wicke,L.,  Prey,T.,  Reisinger,L. (1975)  –  Pollendiät als Adjuvans der Strahlentherapie gynäkologisscher Karzinoma (German) (Pollen diet as an adjuvant of radiotherapy in gynaecologic carcinomas),
     in Strahlentherapie 150,  p.500-506 (***-abstract in English[1]).

 

 

·        Ialomiteanu, M. (1978) (Romania)    Pollen. Food and Drug. Biostimulative and therapeutically value (Romanian). (p.142-144).          Apimondia Publishing House. Bucharest. 158 pp. (***).

 

 

·        Lee, H. William (1983) (USA)  –  Bee Pollen. Super Energy-Super Nutrition.
     Pine Grove Pamphlet Division of Keats Publishing ,Inc.
New Canaan, Connecticut.  ISBN 0-87983-353-X.  16 pp. (***).

 

 

·        Li Shi-yuan,  Chen Yu-wen,  Zou Qi (1995) (China)  –  Clinical application of BWP (broken wall pollen) in curing various kinds of anaemia,   
     in Apiacta XXIX,  pp.40-41 (***).

 

 

·        Lyngheim Linda,  Scagnetti, Jack (1979) (USA)   Bee Pollen. Nature’s Miracle Health Food.
     Melvin Powers. Wilshire Book Company.
North Hollywood, California.  ISBN 0-87980-371-1.  90 pp. (***).

 

 

·        Mickevicius,Juozas,  Milasiene,Vida,  Breivis,P.,  Kersiene,R.,  Narbutiene,G.,  Kadziauskiene,Kamelija,  Norkiene,V. (1997) (Lithuania)  –  Use of honey and pollen in the chemotherapy of cancer patients,
     in the XXX-Th. Apimondia Congress, Antwerp, Belgium (***). [iii]

 

 

·        Robinson, W. (1948)  –  Delay in the appearance of palpable mammary tumors in C3H mice following the ingestion of pollenized food,
     in J. Nat. Cancer Inst. 9,  pp.119-123.

 

 

·        Wang Weiyi,  Hu Junxiang,  Cheng Jianbin (1987) (China)  –  L’éffet biologique radioprotecteur du pollen sur les tissus hematopoietiques chez les souris irradiées,
     in the XXXI-St.
Apimondia Congress, Warsaw, Poland,  p.566 (***-abstract).

 

 

·        Wang, W.;  Hu, J.;  Cheng, J. (1984)  –  Biological effect of honey bee pollen: I. radioprotective activity on haematopoietic tissues of irradiated mice,
     in J. Hangzhou Univ. 11,  pp.231-240.

 

 

·        Wang Weiyi,  Shen Shaobo (1989) (China)  –  The in vitro effect of rape pollen on T lymphocyte proliferative response in rats,
     in the XXXII-Nd. Apimondia Congress, Rio de Janeiro, Brazil,  p.557-58 (***-English, French, German and Spanish abstracts).

 

 

·        Xu Lingen,  Wang Mingrong,  Wang Weiyi,  Du Xingfa (1989) (China)  –  Efficacy and mechanisms of pollen in anti-cancers and anti-ageing,
     in the XXXII-Nd. Apimondia Congress, Rio de Janeiro,  Brazil,  p.548 (*** – French, English, German [iv] and Spanish abstracts).

 

 



[1] The introduction of a pollen diet as an adjuvant in the reduction of side effects during radiotherapy of patients with gynaecological cancer is described and its efficacy evaluated. 15 women with carcinoma of the cervix received a pollen diet during irradiation, whilst ten further patients receiving irradiation served as controls without pollen added to the diet. Serum enzymes, proteins, vitamins and blood count were analysed before and after irradiation. It appears, that pollen favourably influences the efficacy of irradiation and reduces the frequency of side effects, both subjectively and objectively.
PMID: 2995 [PubMed – indexed for MEDLINE].



[i] Author’s address:
Chernovtsy Medical Institute, Chernovtsy State University, Ukraine.

Abstract:
It has been established that small x-irradiation dozes activate the lipid peroxidation and antioxidant system enzymes in mice liver. The introduction of bee pollen extract to animals normalized the activity of only several glutathione system enzymes in mice liver.

PMID: 9583135 [PubMed – indexed for MEDLINE]

 

[ii] Abstract:

The state of erythrocyte redox system of rats feeding on apis flower pollen load during a month was investigated. It was established that the content of glutathione, total SH-groups as well as activities of glutathione peroxidase and glutathione reductase in these animals in comparison with the control group were increased. Simultaneously a decrease of malondialdehyde and dienic conjugates in erythrocytes was shown. The activity of catalase and superoxide dismutase were increased, but it was not statistically reliable. A conclusion was made that the antioxidative system is nonspecifically activated and oxidative processes are blocked in erythrocytes of rats fed on apis flower pollen load.
PMID: 7785093 [PubMed – indexed for MEDLINE]

 

 

[iii] THE USE OF HONEY AND POLLEN IN THE CHEMOTHERAPY OF CANCER  PATIENTS

 

                                                              J. MICKEVICIUS, V. MILASIENE, P. BREIVIS,                R. KERSIENE, G NARBUTIENE,  K. KADZIAUSKIENE, V. NORKIENE

                                (LITHUANIA)

 

Our investigation indicates positive changes caused by honey and pollen in the immune and antioxidative systems, when applying surgical treatment to gastric and colon-rectal cancer patients.

             The aim of this work is to evaluate the impact of honey and pollen on the immune system and on the antioxidative and blood-forming systems in gastric and colon-rectal cancer patients, when they are administered chemopreparations.

76 patients with gastric and colon-rectal cancer have been investigated, as they were administered chemopreparations. 41 of them used honey and pollen simultaneously with the specific treatment and 35 used chemopreparations, but no bee products.

The Lithuanian Nutrition Center performed hygienic, chemical composition and biological analyses on honey and pollen.

The hematological indicators (leucocytes, lymphocytes, neutrophiles, monocytes, thrombocytes); the indicators of cell and humoral immunity (T-lymphocytes (CD3+), T-helper cells (CD4+), T-cytotoxic cells (CD8+), B-lymphocytes (CD20+), natural killers (CD16+): the blast level and the activity of neutrophiles (by the NTB test), as well as the G, A, M class immunoglobulin concentration in the peripheral blood circulation and the indices that reflect the activity of the antioxidant system (DK and MDA value and SOD -superoxydismutasis-  activity) were determined in the respective patients.

The analysis of the data obtained showed that the patients who did not use bee products had a lower level of CD3+, CD4+, CD8+, CD20+ and CD16+ cells but the MDA concentration in their peripheral blood circulation increased.  Other statistical indicators did not change.

In the patients using bee products, we noticed an increase in the number of CD3+ cells during the treatment, while the number of CD4+, CD8+, CD20+ and CD16+ cells did not change statistically and the MDA and DK value decreased in the peripheral blood circulation.
          In this group, the number of thrombocytes also decreased during the treatment.

The results obtained indicate that bee products cause positive changes in some indicators of the immune and antioxidative systems in patients with gastric and colon-rectal cancer in the third and the fourth stage, when they are subject to chemotherapy.

 

                                                                                                                                                  p.122-123

[iv] WIRKSAMKEIT UND WIRKUNGSMECHANISMUS  DES POLLENS GEGEN KREBS UND ALTERN

                                                                                                                XU LINGEN

                                                                                                                WANG MINGRONG

                                                                                                                WANG WEIYI
                                                                                                                DU XINGFA (China)
 

Die vorliegende Arbeit enthält sowohl eine ausführliche Beschreibung der Wirksamkeit des Pollens bei Krebs und Altern als auch eine Zusammenfassung der betreffenden Mechanismen. Die Autoren sind der Meinung, daß der Pollen die Immunität gegen Infektionen steigert, die Jugendzeit verlängert und die krebsarti­gen Gebilde hemmt.
               
S.548

References on the use of Royal jelly against cancer:

 

·        Belvefer, B.;  Gautrelet, M. (1965) (France)   The importance of the dihydroxy-decenoic acid found in natural condition in royal jelly,
     in the XX-Th. Apimondia Congress, Bucharest, Romania,  pp.544-46 (***).

 

 

·        Huang, Q. and 4 others (1987)  –  Establishment of human glioma cell line nude mice solid tumour model NHG-1 and its characteristics,
     in Chung Hua Chung Liu Tsa Chih 9(4),  pp. 269-272.[i]

 

 

·        Grad, B.;  Kral, V. A.;  Berenson, J. (1961) (Canada)    Toxic and protective effects of royal jelly in normal and diseased mice,
     in Canadian Journal of Biochemistry and Physiology, Vol. 39 (***).

 

 

·        Huang Q, Du ZW, Xu GD, Liu ZY, Guo YH, Chen GL, Ma WX, Tan QY, Xu QN, Li B, et al. (1987) (China)  –  Establishment of human glioma cell line nude mice solid tumour model NHG-1 and its characteristics (article in Chinese),
     in Zhonghua Zhong Liu Za Zhi 1987 Jul;9(4):269-72. [ii]


First Hospital, Suzhou Medical College.

Establishment and its characteristics of a nude mice solid tumor model NHG-1 from human glioma cell line are reported. 5-8 week old NC nude mice of both sexes and SHG-44 cell line used in this experiment were from our laboratory. The initial successful transplantation rate was 7/11 (64%) and that of 30 passages in the subsequent 4 years was 100%. After subcutaneous inoculation, growth curve showed a latent period in week 1-2, slow growing period in week 3-4, rapid growing period in week 5-6 and a final plateau period in week 7. The doubling time was 7 days and cell cycle time was 2.5 days. The cells in G1, S and G2M phases comprised 56%, 27% and 17%, respectively. The survival time of the host was 54 +/- 15 days. The tumor tissues showed a tendency towards invading the surrounding soft tissues. By morphological observation with light and electron microscopes, LDH isozyme assay, PAP immuno-histochemistry labelling GFAP and chromosome analysis, it is confirmed that the transplantable tumor possesses the characteristics of human malignant glioma. The estrogen receptor in the transplantable tumors demonstrated by cytochemical assay indicates that the glioma carcinogenesis is related to endocrine factor of the host. The therapeutic effects of anticancer drugs, such as ACNU, BCNU and 10-hydroxy-2-decenoic acid from the royal jelly on NHG-1 model are evaluated.

PMID: 3678017 [PubMed – indexed for MEDLINE]

 

 

·        Kushima,S. (1985) (Japan)  –  Studiu asupra efectului medicamentos al lãptisorului de matcã (Romanian),
     in the XXX-Th. Apimondia Congress, Nagoya, Japan,  pp.436-41 (***).

 

 

·        Tamura, T.;  Fujii, A.;  Kuboyama, N. (1985)  –  L’effet de la gélée royale sur les tumeurs experimentales transplantables,
     in the XXX-Th.
Apimondia Congress, Nagoya, Japan,  pp.494-498 (***).

 

 

 

·      Tamura, T.;  Kuboyama, N.;  Fujii, A. (1985)  –  Studies on mutagenicity of royal jelly,
       in Honeybee Science 6(1),  pp.7-12;
       in the XXX-Th. Apimondia Congress, 10-16 Aug. 1985,  p.153 (abstract).

Abstract:
 Tumour growth inhibition in mice has been shown with both prophylactic (preventative) and direct therapeutic treatment, when royal jelly was given orally.  Inhibition of rapid-growth cancers (e.g., leukaemia) was insignificant, but was noticeable on slow-growing, solid tumours such as sarcomas Ehrlich carcinoma.  Royal jelly showed significant growth inhibition (from 25.3 to 59.7%) and increased life span (19.3 to 20.4%) in experimental mice with these tumours when they were fed daily doses of from 10 to 1000mg/kg.

 

 

·      Tamura T, Fujii A, Kuboyama N. (1987) (Japan)  –  Antitumor effects of royal jelly (RJ) (article in Japanese),
      
in Nippon Yakurigaku Zasshi, 1987 Feb;89(2):73-80.

Antitumor effects of Royal Jelly (RJ) were investigated employing the transplantable tumors of mouse advance leukemia L1210 and P388 strains and Ehrlich, Sarcoma-180 ascites and solid tumor strains. RJ was administered orally in a prophylactic-therapeutic (30 days before and 30 days after the transplantations of tumor cells) or a therapeutic (30 days after the transplantations of tumor cells) manner. Tumor cells were transplanted i.p. (ascites tumor) or s.c. (solid tumor). The daily dose of RJ was 0 (control), 10, 100, or 1000 mg/kg. In the case of the therapeutic experiments employing advance leukemia L1210 and P388 strains, which gave quite a short survival period of 8 approximately 9 days, RJ did not show any antitumor effect. In the case of the therapeutic RJ application employing the Sarcoma-180 ascites tumor, which gave a moderate survival period of 16 days, the increased life span was 9.3 approximately 19.3%; and with the Ehrlich ascites tumor (survival period of 22.1 days), the increased life span was 20.4% (RJ 10 mg/kg . day) and 17.6% (RJ 1,000 mg/kg . day), but no antitumor effect was observed at the dose of 100 mg/kg/day. In the case of the therapeutic experiment employing Ehrlich solid tumor, tumor growth inhibition was 25.3 approximately 54.8%, where as the use of the prophylactic-therapeutic regimen gave a tumor growth inhibition of 38.3 approximately 45.7%. In the case of the therapeutic RJ application employing Sarcoma-180 solid tumor, tumor growth inhibition was 45.1 approximately 59.7%, where as the prophylactic-therapeutic regimen gave a tumor growth inhibition of 49.1 approximately 56.1% (ABSTRACT TRUNCATED AT 250 WORDS).

PMID: 3570105 [PubMed – indexed for MEDLINE]

 

 

·        Tamura, T.;  Kuboyama, N.;  Fujii, A. (1985)  –  Études sur la mutageneité de la gélée royale,
     in the XXX-Th.
Apimondia Congress, Nagoya, Japan,  pp.498-501 (***).

 

 

·        Townsend,G.F.,  Morgan,J.F.,  Tolnai,S.,  Hazlett,B.,  Morton,H.J., Shuel,R.W. (1960)  –  Studies on the in vitro antitumor activity of fatty acids I. 10-hydroxy-2-decenoic acid from royal jelly,
     in Cancer Res. 20,  pp.503-510.

 

 

 



[i] Royal jelly and 10-HDA have shown anti-tumour activity in experimental mouse leukemias and endocrine responsive human gliomas (nervous system tumours) in mice.

 

[ii] Royal jelly and 10-HDA have shown anti-tumour activity in experimental mouse leukemias and endocrine responsive human gliomas (nervous system tumours) in mice.